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introDUction
This thesis focuses on the selection of psychotherapy treatment in patients with 
personality disorders (PD). In four different studies, clinical knowledge and prac-
tice findings on treatment selection and effectiveness of treatment selection are 
investigated. This thesis aims to contribute to evidence-based treatment selection 
for patients with PD.
Personality DisorDers
PDs are among the most common mental disorders in the general population and 
psychiatric healthcare settings. The reported prevalence rates are between 7.3 and 
15.7% (Crawford et al., 2005; Klein et al., 1995; Lenzenweger, Lane, Loranger, 
& Kessler, 2007; Maier, Lichtermann, Klingler, Heun, & Hallmayer, 1992; Moldin, 
Rice, Erlenmeyerkimling, & Squireswheeler, 1994; Samuels et al., 2002; Torg-
ersen, Kringlen, & Cramer, 2001; Zimmerman & Coryell, 1989). Research has 
shown that well-being and functioning of individuals suffering from PD is largely 
impaired, and that this is indeed due to the presence of PD (Cramer, Torgersen, & 
Kringlen, 2006; Soeteman, Verheul, & Busschbach, 2008). The diagnostic criteria 
used in this thesis are based on the DSM-IV-TR (American Psychiatric Associa-
tion, 2000), which defines PD as “an enduring pattern of inner experience and 
behavior that deviates markedly from the expectations of the individual’s culture, is 
pervasive and inflexible, has an onset in adolescence or early adulthood, is stable 
over time, and leads to distress or impairment”. The DSM-IV-TR general diagnostic 
criteria for PD are provided in Table 1.1.
The DSM-IV-TR defines PDs in terms of personality traits, which are enduring 
patterns of perceiving, relating to, and thinking about the environment and oneself 
that are exhibited in a wide range of social and personal contexts. The emphasis 
on traits in the DSM-IV-TR establishes the possibility of a conceptual continuity 
between normal and disordered personality (Livesley, 2001). Furthermore, the 
polythetic format for diagnosis implies that PDs are combinations of traits and 
leads to considerable heterogeneity within one specific PD category.
There are ten officially recognized PDs, classified in three clusters; cluster A, 
i.e. the odd cluster, including the Paranoid, Schizoid and Schizotypal PD, cluster 
B, i.e. the dramatic cluster including the Antisocial, Borderline, Histrionic, and 
Narcissistic PD and cluster C, i.e. the anxious cluster including the Avoidant, 
Dependent and Obsessive-Compulsive PD. Apart from these ten, the classification 
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comprises a ‘not otherwise specified’ category (PD NOS), including two provi-
sional diagnoses, i.e. depressive PD and passive-aggressive PD.
The PDs should be distinguished from clinical symptoms such as depression 
and alcohol dependence. The DSM-IV-TR uses a “multiaxial” system for assess-
ment. PD’s are placed on axis II, distinct from the clinical disorders that are placed 
in axis I. Assessing PD’s on a separate axis recognizes the clinical significance 
and high prevalence. PD’s differ from clinical syndromes in the extent to which 
they are rooted in the character of the individual, with PDs being more interwoven 
with the character structure.
Both the definition and classification of PDs has been subject to criticism. The 
DSM-IV-TR classification simplifies professional communication and encourages 
empirical research, but has limited clinical utility (Tyrer, 2010). To enhance clinical 
utility, in the new DSM-5, section III, ‘Emerging Measures and Models’ a revision 
of the assessment of PD has been proposed (American Psychiatric Association, 
2013). In this revision the general definition of PD is modified, four types are 
discarded (i.e., Paranoid, Schizoid, Histrionic, and Dependent PD), and two 
components are added: five severity levels of personality functioning, and a 
dimensional description of the patient in terms of personality trait domains. The 
present research was conducted between 2003 and 2006, and is therefore still 
based on the DSM-IV-TR definition of PD.
Table 1.1. General diagnostics criteria for a DSM-IV Axis II Personality disorder (APA 2000)
A An enduring pattern for inner experience and behavior that deviates markedly from the 
expectations of the individual’s culture. This pattern is manifested in two (or more) of the 
following areas:
1. Cognition (i.e. ways of perceiving and interpreting self, other people and events) 
2. Affectivity (i.e. the range, intensity, lability and appropriateness of emotional response) 
3. Interpersonal functioning 
4. Impulse control 
B The enduring pattern is flexible and pervasive across a broad range of personal and 
social situations.
C The enduring pattern leads to clinically significant distress or impairment in social, 
occupational, or other important areas of functioning.
D The pattern is stable and of long duration and its onset can be traced back at least to 
adolescence or early adulthood.
E The enduring pattern is not better accounted for as a manifestation or consequence of 
another mental disorder.
F The enduring pattern is not due to the direct physiological effects of a substance (e.g. a 
drug of abuse, a medication) or a general medical condition (e.g. head trauma).
11
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The most reliable and valid strategy to diagnose PDs is the Longitudinal Expert 
All Data (LEAD) method (Spitzer, 1983). Its application is time-consuming, and 
therefore less feasible in clinical practice. The second best option is to conduct a 
semi-structured interview, such as the SIDP-IV (Jong, Derks, Oel, & Rinne, 1995) 
or SCID-II (First, 1997).
Personality DisorDers anD treatment
Systematic review studies have concluded that psychotherapy is an efficacious 
treatment for patients with PD, with mean effect sizes ranging between approxi-
mately 1.0 and 2.5 for various outcome parameters (Bateman & Fonagy, 2000; 
Leichsenring & Leibing, 2003; Perry, Banon, & Ianni, 1999). Since then, consen-
sus has grown that psychotherapy is the treatment of choice for patients with PD 
(Landelijke Stuurgroep Multidisciplinaire Richtlijn ontwikkeling in de GGZ, 2008; 
National Institute for Health and Clinical Excellence, 2009a, 2009b). Effective 
psychotherapies for PD include a range of treatments, varying in setting (e.g. 
outpatient versus inpatient), duration (e.g. short-term versus long-term), format (e.g. 
individual versus group) and theoretical background (e.g. cognitive behavioural 
versus psychodynamic). This variety of treatment options raises the classical ques-
tion: “What treatment, by whom, is most effective for this individual with that 
specific problem, under which set of circumstances?” (Paul, 1967). However, as 
yet, this question has not been investigated empirically. Research on predictors, 
moderators and mediators of treatment effectiveness has not sufficiently evolved 
to allow for definite treatment selection guidelines (Critchfield & Benjamin, 2006). 
Therefore, in deciding what treatment to select for a particular patient, the clini-
cian is not much helped by empirical research findings, and he or she will have to 
resort primarily to clinical judgment. The current evidence from empirical research 
can be summarized as follows:
- Selection to treatment duration
 Longer treatment predicted positive outcome in cluster B patients (Chiesa & 
Fonagy, 2007)
- Selection to treatment setting
 Our research group has investigated the effectiveness and cost-effectiveness 
of five different treatment modalities by combining duration (i.e. short-term 
versus long-term psychotherapy) with treatment setting (i.e. outpatient, day 
hospital, versus inpatient). For cluster C PD, short-term inpatient psychotherapy 
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resulted in significantly more improvement of all outcome measures than did 
most other treatment modalities (Bartak et al., 2010) and was also the most 
cost-effective choice (Soeteman et al., 2011). For cluster B PD, psychiatric 
symptoms of patients in inpatient treatment improved marginally but neverthe-
less significantly more than those of patients in outpatient treatment (Bartak, 
Andrea, Spreeuwenberg, Ziegler, et al., 2011). On the other hand, the most 
cost-effective variant was outpatient psychotherapy (Soeteman et al., 2010). 
For cluster A PD, improvements were shown in all settings, but as sample sizes 
were small, it was not possible to empirically compare them (Bartak, Andrea, 
Spreeuwenberg, Thunnissen, et al., 2011).
- Selection to treatment intensity/level of destabilisation
 Various studies have demonstrated theoretical differences between a support-
ive and an interpretive form of psychodynamic psychotherapy. None reported 
(large) differences in effectiveness; however, they demonstrated differences in 
drop-out rate. In cluster C PD, the supportive variant was associated with a 
remarkably lower drop-out rate than that found with the interpretive or expres-
sive variant (Piper, Joyce, McCallum, & Azim, 1998; Piper, McCallum, Joyce, 
Azim, & Ogrodniczuk, 1999; Winston et al., 1994; Winston et al., 1991)
- Selection to theoretical orientations
 The theoretical orientation does not seem to be crucial to the efficacy of 
psychotherapeutic treatment for PD (Verheul & Herbrink, 2007). Bateman 
and Fonagy (2000) concluded that the efficacy is rather determined by the 
consistent application of a coherent and understandable – both to patients and 
to therapists  –theoretical frame. Furthermore, many psychotherapies for PD 
are in fact integrated treatments with elements from various specific theoretical 
orientations. An example is schema therapy, which combines elements from 
cognitive-behavioural, psychodynamic, and experiential psychotherapies.
scePtre – stUDy on cost-effectiveness of Personality DisorDer 
treatment
Two studies presented in this thesis are based on data from a large prospective 
psychotherapy investigation in the Netherlands, the Study on Cost-Effectiveness of 
Personality Disorder Treatment (SCEPTRE). Patients were recruited from six mental 
healthcare institutions: De Viersprong (Halsteren), Mentrum/Arkin (Amsterdam), 
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Zaans Medical Centre (Zaandam), Altrecht (Utrecht), De Gelderse Roos/Pro Per-
sona (Lunteren), and GGZWNB (Bergen op Zoom/Roosendaal). These institutions 
offer specialized psychotherapy for adult PD patients. More than 900 patients 
with personality pathology were included between 2003 and 2006, and they 
were followed for five years. The study aimed to determine the effectiveness and 
cost-effectiveness of different ‘dosages’ of psychotherapy for patients with PD, 
treatment selection was addressed as well. To overcome the problem of selection 
bias in the naturalistic design of SCEPTRE, we controlled for initial differences 
in patient characteristics with the propensity score method (Bartak et al., 2009; 
Spreeuwenberg et al., 2010; van Eeren et al., 2011). SCEPTRE has a high follow-
up response, so that the results are meaningful for clinical practice.
aims anD research qUestions
The primary aim of this thesis is to investigate A) clinical knowledge; B) routine 
clinical practice, and C) empirical evidence of treatment selection for patients with 
PD. The secondary aim is to contribute to evidence-based treatment selection in 
clinical practice. In this context, we addressed the following research questions:
A. Clinical knowledge
 1.  What patient characteristics are considered relevant to treatment selection 
for patients with PD?
 2.  What matching hypotheses underlie or implicitly underlie clinical practice 
of treatment selection for patients with PD?
B. Routine clinical practice
 3.  What is the relationship between characteristics of patients with PD and 
treatment allocation in routine clinical practice?
C. Empirical evidence
 4.  Do patients with high psychological strength profit more from predominantly 
destabilizing treatments; and do patients with low psychological strength 
profit more from predominantly stabilizing treatments?
the format of this thesis
Chapter 2: using a consensus method, patient characteristics are identified that 
might be of clinical use in treatment selection (research question 1);
Chapter 1
14
Chapter 3: explored clinical knowledge on treatment selection by interviewing 
expert clinicians (research question 2);
Chapter 4: explored the most important factors influencing treatment selection in 
routine clinical practice, based on the SCEPTRE baseline data (research question 
3);
Chapter 5: the following matching hypothesis was tested: patients with high 
psychological strength profit more from predominantly destabilizing treatments, 
whereas patients low on strengths profit more from predominantly stabilizing treat-
ments, using data from the SCEPTRE study (research question 4);
Chapter 6: discusses the answers to the research question stated above, addresses 
implications for clinical practice, and provides recommendations for future re-
search.
15
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abstract
Using the concept map method, this study aimed to summarize and describe 
patient characteristics pertinent to treatment selection for patients with personal-
ity disorders (PDs). Initial patient characteristics were derived from the research 
literature and a survey among Dutch expert clinicians. Concept mapping is a 
formalized conceptualization procedure that describes the underlying cognitive 
structures people use in complex tasks, such as treatment allocation. Based on 
expert opinions of 29 Dutch clinicians, a concept map was generated that yielded 
eight domains of patient characteristics, i.e. Severity of symptoms, Severity of 
personality pathology, Ego-adaptive capacities, Motivation and working alliance, 
Social context, Social demographic characteristics, Trauma, and Treatment his-
tory and medical condition. These domains can be ordered along two bipolar 
axes, running from internal to external concepts and from vulnerability to strength 
concepts, respectively. Our findings may serve as input for the delineation of 
algorithms for patient-treatment matching research in PD.
Van Manen, J.G., Kamphuis, J.H., Goossensen, A., Timman, R., Busschbach, 
J.J.V., & Verheul, R. (2012). In search of patient characteristics that may guide 
empirically based treatment selection for personality disorder patients – A concept 
map approach. Journal of Personality Disorders, 26(4), 481-497.
Van Manen, J.G., Goossensen, A., Knapen, P., Ingenhoven, T., De Saeger, H., 
Cornelissen, K., Kamphuis, J.H., Timman, R., Verheul, R., Busschbach, J.J.V. (2010) 
Concept mapping of indicators for treatment allocation in patients with personality 
disorders. Retrieved from http://repub.eur.nl/res/pub/20870/
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introDUction
Effective psychotherapies for personality disorders (PDs) include a range of treat-
ments, varying in setting (e.g. outpatient versus inpatient), duration (e.g. short-term 
versus long-term), format (e.g. individual versus group) and theoretical background 
(e.g. cognitive behavioural versus psychodynamic). This variety of treatment op-
tions raises the classical question: “What treatment, by whom, is most effective 
for this individual with that specific problem, under which set of circumstances?” 
(Paul, 1967). To date, research has supported the effectiveness of some psycho-
therapeutic treatments (e.g. dialectical behavior therapy, mentalization-based 
treatment and schema-focused therapy) in some PDs (e.g. borderline and avoidant 
PD). However, research on moderators and mediators of treatment effectiveness 
has not sufficiently evolved to allow for definite treatment selection guidelines 
(cf. Critchfield & Benjamin, 2006). Therefore, when facing the everyday task of 
deciding which treatment to select for a particular patient, the clinician can only 
derive limited assistance from empirical research, and she/he will have to resort 
to clinical judgment.
Predicting and selecting the optimal treatment for a particular client is a cogni-
tively complex task, as it involves appraising multiple treatment alternatives on mul-
tiple divergent aspects, and performing various probabilistic calculations (Denig, 
Witteman, & Schouten, 2002). Several specific biases have been observed among 
clinicians that may lead to suboptimal treatment selection. For example, clinicians 
tend to conclude that the patient’s problems are caused by personality factors, 
and in so doing underestimate the role of situational factors (Morrow & Deidan, 
1992). Furthermore, clinicians tend to consider only one treatment option per 
case, and consider other treatment options only after the initial selection appears 
to be unsatisfactory (Witteman & Kunst, 1997). In a more general sense, ample 
evidence indicates that clinical judgment is suboptimal for predictive purposes, as 
it is vulnerable to various general cognitive biases. Two meta-analytical studies 
(Aegisdottir, et al., 2006; Grove, Zald, Lebow, Snitz, & Nelson, 2000) have 
convincingly documented that statistical predictions are generally more accurate 
than clinical judgment in prediction.
The present study is part of a larger research program that aims to contribute 
to empirically based treatment selection for PD patients. While our previous work 
explicated clinicians’ actual use of information about patient characteristics to 
select treatments (Van Manen, et al., 2008, 2011), the present study aims to sum-
marize and describe patient characteristics relevant for the selection of the optimal 
psychotherapeutic treatment for patients with personality disorders. In accordance 
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with evidence based medicine, we formulated patient characteristics based on 
both clinical expertise and available empirical evidence (Sackett, Rosenberg, 
Gray, Haynes, & Richardson, 1996).
Concept mapping is a standardized procedure for the conceptualization of 
a specific subject (cf. Kane & Trochim, 2006; Trochim, 1989; Trochim & Kane, 
2005), and is particularly appropriate when a concept is still in its exploratory 
stage as it aids the clarification of the constituent elements (Johnsen, Biegel, & 
Shafran, 2000; Paulson, Truscott, & Stuart, 1999). Concept mapping combines 
qualitative and quantitative research strategies, and the input for the concept map 
can be drawn from different sources such as published research data and/or data 
generated by experts during a brainstorm meeting (Trochim, 1989). The four main 
processes of the concept map procedure are: (1) generation of concepts by par-
ticipants and/or by research data; (2) grouping together of the concepts through 
an ‘unstructured card sort’ by participants; (3) statistical analysis of the card sort 
using multidimensional scaling and cluster analysis, and (4) interpretation of results 
by participants. Concept mapping has previously been used in psychotherapy 
research for such diverse purposes as the description of client perspective on alli-
ance formation (Bedi, 2006) and counselling for suicide (Paulson & Worth, 2002), 
and the mapping of therapeutic common factors (Tracey, Lichtenberg, Goodyear, 
Claiborn, & Wampold, 2003) and coping strategies (Gol & Cook, 2004). In this 
study we used the concept mapping method to describe a manageable number 
of patient characteristics that may serve to formulate actuarial algorithms for treat-
ment selection research in the PD population.
methoD
Participants
A group of researchers and expert clinicians was selected on basis of their specific 
research expertise or expertise in the assessment and/or treatment of PD patients. 
More specifically, the first author (J.G.v.M.) compiled a list of Dutch authors who 
published articles or chapters on the treatment of personality disorders, treatment 
selection in personality disorders, or personality disorders in general. A list of 46 
experts resulted, who received a letter from one of the authors (R.V.) inviting them 
to participate in a structured group process in order to share their knowledge 
on treatment selection in PD patients. This structured process consisted of two 
individual tasks of approximately one hour, and a 4-hour group meeting. To 
encourage participation, the experts received a gift voucher upon finishing the 
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two individuals tasks (i.e. € 25,- for each individual assignment) and again after 
the group meeting (i.e. € 250,- ). Not all experts were able to contribute or attend 
timely to all three parts of the study, nor were they required to. Figure 2.1 displays 
a flow chart detailing the expert participation at each stage of the study. To ensure 
adequate preparation, we required the experts to complete the missed assignment 
even if the resulting data could not longer be included in the analyses. Seventeen 
experts did not respond to any of the three parts of the study, therefore 29 out 
of the 46 Dutch experts participated in one or more of the three different stages 
of the study. This number is relatively high when compared to the average range 
of participants for a concept map procedure (between 10 to 20 participants; 
Trochim, 1989). More participants yield more information and consequently more 
precise results (Trochim, 1993). The participants were between 29 and 64 years 
Participation in generation of 
concepts task (by email)
Participation in the sorting and 
rating task (by 
webapplication)
Participation in interpretation 
session (live 4-hour meeting)
n = 8
Experts aproached to 
participate
No further 
participation
No participation
No further 
participation
n = 4
n = 2
n = 17
n = 10
n = 13
Figure 2.1. Flowchart of the Participation of Experts in the different Stages of the Concept Map 
Procedure
Note. The arrows to the left of the boxes indicate the number of experts who skipped one or 
more stages, while arrows in the middle indicate the number of experts who proceeded to the 
subsequent steps. Drop-out at each stage is indicated by the arrows and the boxes to the right.
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old, (M = 49.0; SD = 9.0), and reported an average of 21 years of professional 
experience (SD = 9.5). Most were licensed clinical psychologists (n=15, 52%), 
followed by psychiatrists (n=7, 24%), licensed psychotherapists (n=4, 14%), and 
clinical researchers (n=3, 10%). Both sexes (men n=16, 55%; women n=13, 45%) 
and major theoretical orientations were equally represented (cognitive behavioral 
n=9, 31%; psychodynamic n=9, 31%; integrative n=11, 38%).
Procedure
Concept mapping includes four stages: (a) generation of the concepts; (b) sorting 
and rating of the concepts; (c) statistical analysis; and (d) interpretation session.
Generation of the concepts
The concept mapping procedure starts with the generation of a set of concepts 
that ideally represent the entire conceptual domain of interest (Trochim, 1989), 
i.e. in this study the patient characteristics that seem of importance in the treat-
ment selection process for PD patients. We combined two sources for the concept 
generation process, i.e. (1) a literature search, and (2) expert opinion. Two 
electronic databases (PsycINFO, PubMed) were used for the literature search into 
articles and chapters on treatment selection in personality disorders. Keywords 
used were personality disorder(s) in combination with client characteristics, patient 
selection, client treatment matching, patient care planning, or treatment planning. 
The database search was conducted in the spring of 2008 and was restricted 
to Dutch and English language papers published after the first of January 1990. 
Additional papers were identified by searching the reference list of retrieved 
articles. The search resulted in 55 articles or chapters. More details on the search 
strategy (including a reference list) can be found in an online available research 
report (http://repub.eur.nl/resource/pub_20870/index.html). From the selected 
sources 310 concepts were distilled. As Kane and Trochim describe in their guide 
to concept mapping, the number of concepts and their clarity to the participants 
are the key factors of success of the concept mapping process (Kane & Trochim, 
2006). Frequently, steps must be taken to prune and edit the retrieved concepts. 
Using a small group of participants or researchers for key decisions in the formula-
tion of concepts, and using simple editing rules is generally sufficient for reducing 
and editing the concepts (Bedi & Alexander, 2009; Gol & Cook, 2004; Kane & 
Trochim, 2006). Based on the editing rules of Kane and Trochim (2006) and Gol 
and Cook (2004), six rules of concept editing were specifically formulated for the 
present study and applied by the first author (J.G.v.M.): (1) selecting patient char-
acteristics only (e.g. drop other concepts like ‘theoretical orientation of therapist’); 
25
a ConCept map of treatment seleCtIon for pD patIents
(2) eliminating duplicate concepts; (3) editing for clarity and comprehension; (4) 
seeking optimal specificity in the formulation; (5) equalizing the level of abstrac-
tion (e.g. use only symptoms or only diagnosis, but not both); and (6) stipulating a 
maximum number of concepts of 100 (manageability). When these editing rules 
failed to provide decisive formulation, the first author consulted a core group of 
concept map participants to discuss optimal formulation of the concepts. Employ-
ment of these rules resulted in 68 concepts or patient characteristics, which were 
subsequently sent to 46 participants by email, with the request to supplement 
and/or clarify the concepts. Of the 46 invited experts, 17 (37%) replied (see 
Figure 2.1). The suggestions of the experts were processed which resulted in a 
revised list of 126 patient characteristics. The previously explicated six rules were 
again applied by the first author (J.G.v.M.) with help of the core group, which 
resulted in a third and final list of 81 patient characteristics.
Sorting and rating of concepts
In the next phase, all 46 experts were invited to perform the sorting/rating tasks, 
to which 18 (39%) experts complied (see Figure 2.1). For the sorting and rating 
tasks we used a personalized web application, derived from www.conceptsys-
temsglobal.com. For the sorting task, the participants were instructed to group 
the patient characteristics in a way that makes sense to you, with the purpose of 
making conceptually homogeneous clusters. Restrictions on the sorting task were: 
(1) a patient characteristic can not be placed in a pile by itself (i.e. a pile must 
consist of more than one patient characteristic), (2) not all patient characteristics 
can be placed in one pile (i.e. more than one pile is required), (3) piles named 
‘miscellaneous’ and ‘other’ are not allowed (i.e. piles should have some homo-
geneity), and (4) patient characteristics can not be sorted according to priority 
or importance (i.e. the patient characteristics must be grouped in some content 
oriented way).
As a preliminary analysis, all individual data sorts were aggregated into one 
data matrix, which involved two steps. First, each participant’s sorting solution 
was put into a binary similarity matrix, with as many rows and columns as there 
are patient characteristics (81). A 1 is entered into the cell when the two patient 
characteristics were grouped together in a pile, and a 0 when they are not grouped 
together. Second, all individual binary similarity matrices were summed to obtain 
a combined group similarity matrix.
For the rating task, experts were instructed to rate the importance of each 
patient characteristic for the final treatment selection decision on a 6 point Likert 
scale ranging from 1 (absolutely not important) to 6 (extremely important).
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Statistical analysis
Two statistical procedures were sequentially performed. First, a nonmetric Mul-
tidimensional Scaling (MDS) analysis was performed to represent the patient 
characteristics and their cohesion in a two-dimensional plane. MDS generates 
a spatial representation of the latent organization of a set of items based on the 
frequency with which the items are sorted together (Kruskal & Wish, 1978). In 
other words, MDS arranges the different patient characteristics visually along axes 
in such a way that the distance between two patient characteristics is inversely 
related to the frequency of the two patient characteristics being sorted together. In 
MDS the gold standard is to determine the optimal number of dimensions based 
on diagnostic statistics, which in theory can yield as many as N – 1 dimensions, 
where N is the number of concepts (Kane & Trochim, 2006). However, in the con-
cept mapping procedure it is custom to limit the solution to two dimensions (axes). 
The reason is that the concept map approach is less interested in determining the 
statistically optimal number of dimensions, but instead it places more emphasis 
on the interpretability of the map and its ability to portray the relations between 
the different items in terms of distance and proximity. Furthermore, solutions with 
three or more dimensions quickly become too complicated to interpret (Kane & 
Trochim, 2006; Kruskal & Wish, 1978). The fit of the solution is estimated with a 
stress indicator. The stress indicator measures the mismatches between the MDS 
distances and the observed similarities in the sorted data. It ranges from 0 (no 
discrepancy between distances on the MDS map and observed similarities) to 
1 (the distances in the MDS map have no relation to the observed similarities). 
According to Trochim (1993), approximately 95% of concept mapping projects 
yield stress values between 0.205 and 0.365.
The second statistical analysis forms clusters of patient characteristics. A hierar-
chical cluster analysis using Ward’s minimum variance algorithm was applied to 
the MDS coordinates. In this way internally consistent and non-overlapping clus-
ters of patient characteristics were created. The result is a cluster tree that shows 
step by step which patient characteristics are joined when the number of clusters 
decreases from 81 clusters to 1 cluster. Following Bedi (2006) three criteria to 
select the number of clusters were used: (1) the range of clusters should account 
for the richness of the information on the one hand, but should still be interpretable 
on the other hand (i.e. 5 to 15 clusters), (2) the cluster bridging values1 should be 
1 The bridging value, ranging from 0 to 1, indicates how often a patient characteristic was sorted with 
others that are close to it on the map or whether it was sorted with characteristics that are farther away on 
the map (Concept Systems, 2003). Low bridging values indicate a ‘tight’ relationship with other patient 
characteristics nearby, high values indicate a tendency ‘to bridge’ to patient characteristics all over the 
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low, indicating that the patient characteristics within the clusters were frequently 
sorted together, but not frequently with patient characteristics from other clusters, 
(3) the final cluster solution should be close to the average number of piles selected 
by the participants (i.e. mean +/- 1 SD). All analyses were performed using the 
‘Concept Systems’ computer program (Concept Systems, 2003).
Importance ratings of the patient characteristics were used to calculate the 
mean importance of the clusters. The differences in importance between the clus-
ters were tested with t-tests using a Bonferroni correction for multiple testing.
Trochim (1993) recommends calculating the reliability of the final concept 
map. We calculated the accuracy reliability as described by Jackson and Trochim 
(2002; Trochim, 1993), and Bedi (2006). Accuracy reliability is the association 
between each individual sort and the total group sort. It is calculated as the aver-
age of the correlations between each individual binary similarity matrix and the 
total group similarity matrix (Bedi, 2006). High reliability indicates that the total 
group sort is a trustworthy indicator of the individual sorts. In a meta-analysis of 
33 concept map studies, Trochim (1993) found a mean accuracy reliability of 
0.29 (SD = 0.04)2, Bedi (2006) found in his study an accuracy reliability of 0.45 
(SD = 0.11). We compared our results with the accuracy reliability of Trochim 
(1993) and Bedi (2006).
Interpretation session
In the final phase of the concept mapping procedure, the resulting concept map 
was interpreted in a 4-hour meeting among the participating experts. Of the 46 
invited experts, 19 (41%) took part in the interpretation session (see Figure 2.1). 
The goal of the interpretation session was twofold: (1) interpret and name the 
concept map clusters, and (2) describe the underlying two axes of the concept 
map.
map. Patient characteristics with higher bridging values are more difficult to interpret. Cluster bridging 
value is the average of the bridging values of all patient characteristics in a cluster, and is an indicator for 
the homogeneousness of the patient characteristics in a cluster.
2 Following the line of reasoning advocated by Bedi (Bedi, 2006), we eliminated Trochim’s unconven-
tional use of the Spearman-Brown correction on the reliability values. The value presented is without the 
Spearman-Brown correction.
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resUlts
Generation of the concepts
As presented in Table 2.1, the review of the literature and expert opinion yielded 
81 patient characteristics putatively relevant for treatment selection for PD patients.
Sorting and rating of the concepts
Participants sorted the 81 patient characteristics into an average of 11 piles 
(M  =  10.9, SD  =  3.2). On a scale from one to six, the mean importance of 
a patient characteristic was M = 4.04 (SD = 0.84), suggesting a high overall 
importance of the patient characteristics.
Statistical analysis
The stress value of the MDS-map was .22, indicating a satisfactory fit. First, in 
examining the interpretability of the initial 15 cluster solution, the authors noticed 
that in the step from 8 to 7 clusters 2 clusters merged that seem to have a different 
content. Second, the 8-cluster solution resulted in moderately low cluster bridging 
values, which supports the choice for 8 clusters. Finally, the 8 cluster solution lies 
within the range (+/- 1 SD) of the average number of sorted piles. Therefore, the 
8-cluster solution was chosen as final.
The concept map of the final solution is presented in Figure 2.2. This map is the 
result of the MDS analysis, the hierarchical cluster analyses, and the interpretation 
session with participants (results of the interpretation sessions is discussed in detail 
below). Clusters that are placed far apart, such as Social context and Severity of 
symptoms, indicate that the patient characteristics in these clusters were not sorted 
together very often. On the other hand, the clusters Ego-adaptive capacities and 
Severity of personality pathology are placed next to each other, suggesting a 
tight relationship between these clusters. The average bridging values for each 
cluster is presented in Table 2.1. Bridging values ranged from 0.13 for the most 
homogeneous cluster 7 (i.e. Trauma) to 0.84 for the least homogeneous cluster 8 
(i.e. Treatment history and medical condition).
Table 2.2 shows on the diagonal the mean cluster importance and off-diagonal 
the statistical testing of the mutual differences in importance between the clusters. 
Mean cluster importance was calculated on basis of the expert importance ratings 
of the patient characteristics belonging to each cluster. The clusters Severity of 
symptoms, Severity of personality pathology, Ego-adaptive capacities, and Moti-
vation and working alliance were rated of significantly higher importance than the 
clusters Social context, Social demographical characteristics, and Trauma.
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Table 2.1. Concepts and Clusters derived from the Concept Map, along with their Bridging 
and Rating Values
Clusters and concepts
Bridging
value
(mean)
Rating
value
(mean)
Cluster 1: severity of symptoms 0.19 4.47
9 Anxiety symptoms
11 Posttraumatic stress symptoms (re-experiencing the trauma, nightmares)
21 Suicide attempts
23 Recurrent psychiatric or psychological symptoms
30 Dissociative symptoms
34 Eating problems (binge eating, purging, overweight, underweight)
37 Autism Spectrum Disorder
48 Difficulties with sustained attention or focussing
60 Depressive complaints and/or (hypo)manic episodes
62 Deliberate acts of self-harm
63 Schizophrenia
65 Psychotic episodes
68 Unusual speech (vague, rambling, metaphorical, with excessive 
details, stereotypical)
76 Substance abuse or substance dependence
81 Simulation of psychiatric or psychological symptoms
Cluster 2: severity of personality pathology 0.34 4.26
1 Extreme timidity
3 Severity of personality pathology
4 Number of personality disorders and/or number of maladaptive 
personality traits
12 Psychopathy
13 Anaclitic personality: dependent on love, care and attention from others
28 Focality: the degree to which the symptoms can be described as one core 
problem area, which can explain the symptoms.
35 Pattern of aggressive behaviour
45 Type of personality disorder
50 Neuroticism or emotional stability
51 Perfectionism
80 Personality structure (psychotic, borderline, neurotic)
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Table 2.1. Concepts and Clusters derived from the Concept Map, along with their Bridging 
and Rating Values (continued)
Clusters and concepts
Bridging 
value
(mean)
Rating 
value
(mean)
Cluster 3: ego-adaptive capacities 0.30 4.24
2 Attribution style: attribution of the cause of behaviour to internal, 
dispositional causes, or external, situational causes
6 Capacity to relate: capacity to form intimate, significant and stable 
relationships
33 Attachment pattern
42 Primitive defence mechanisms: the use of for example splitting and 
distortion mechanisms to defend against emotional conflicts or internal or 
external stressors
44 Identity integration: het ability to form stable, integrated and positive 
representations of the self, and the ability to perceive his/her own life as 
meaningful
46 Social skills and adaptability
49 Self-activation: the ability to act when problems need to be solved.
52 Introjective personality: a high level of critical perfectionism and 
autonomous behaviour
53 Level of altruism
57 Obligingness: the tendency to give in, in interpersonal conflicts, to 
avoid quarrels, and to control own anger
59 Ability to mentalize: the ability to understand the mental state of 
oneself and others, such as feelings, thoughts, intentions and wishes
64 Ego strength: de capacity tolerate stress, conflicts and impulses and 
to hold on to one’s own identity versus the risk on fragmentation and 
psychotic reactions
72 Psychological mindedness: the ability to identify dynamic (intrapsychic) 
components and relate them to a person’s difficulties.
73 Extraversion: showing interest and involvement with what is outside the 
self
Cluster 4: motivation and working alliance 0.44 4.53
10 Motivation for treatment: patient takes the responsibility for his/her prob-
lems and feels the urge to overcome these problems despite an possible 
painful process
20 Introspective and reflective capacity: the capacity to observe and think 
of own feelings, fantasies, motives and behaviour
27 Cognitive capacities or intelligence
29 Descriptors of the working alliance between patient and intake 
clinician
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Table 2.1. Concepts and Clusters derived from the Concept Map, along with their Bridging 
and Rating Values (continued)
Clusters and concepts
Bridging 
value
(mean)
Rating 
value
(mean)
32 Reaction on trial interventions: increased motivation, positive affect, 
expression of appreciation or agreement, intense fear, confusion, 
fragmentation, disintegration, primitive defence mechanisms
54 A position of trust in the commitment and motives of the intake 
clinicians
69 Therapy allegiance
75 Level of problem recognition
Cluster 5: social context 0.38 3.81
5 Quality of the social network or support system
25 Dutch fluency
26 Meaningful daily activities (e.g. work, parental care, study, volunteer 
work)
77 Hobby’s
78 Wish of continuing work or study
79 Patient can not be absent for his/her children
Cluster 6: social demographic characteristics 0.28 3.48
14 Judicial status (e.g. arrests, sentence, unresolved legal situation)
17 Age
24 Life stage
31 Patient can bear the treatment expenses
36 Patient’s preference for treatment like the setting or duration of 
treatment
38 Couple- family- or systemic problems
40 Gender
41 Social class
55 No permanent address
56 Considerable outstanding debts
61 Cultural background
70 Education
74 Religion
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The accuracy reliability for the resulting concept map was 0.56 (SD = 0.06; 
t17 = 37.2, p<0.001), indicating adequate reliability for our data.
Interpretation session
During the interpretation session the participants were asked to describe the 
clusters that had emerged from the concept mapping procedure. Below these 
descriptions are provided, starting at the bottom cluster in Figure 2.2 and proceed-
ing anticlockwise.
The bottom cluster was named Severity of symptoms. To the experts, the content 
of this cluster appeared to refer to the manifestation of various mental disorders, 
and to the burden of these symptoms for the patient or his/her environment. The 
cluster includes mainly symptoms from DSM-IV axis I-disorders such as substance 
abuse (76) and anxiety disorders (9).
The second cluster was named Severity of personality pathology. To the experts, 
the content of this cluster appeared to refer to the level of maladaptive function-
Table 2.1. Concepts and Clusters derived from the Concept Map, along with their Bridging 
and Rating Values (continued)
Clusters and concepts
Bridging 
value
(mean)
Rating 
value
(mean)
Cluster 7: trauma 0.13 3.20
7 Sexual abuse after infancy
15 Overinvolvement attitudes from parents/guardians in infancy
19 Sexual abuse after infancy
22 Emotional or physical neglect in infancy
43 History of being bullied
47 Continuing and/or actual traumatic circumstances
58 Parental violence (physical, verbal) in infancy
66 Loss or separation of parents/guardians during childhood
67 Parental divorce in infancy
Cluster 8: treatment history and medical condition 0.84 4.12
8 Treatment history: sort of treatment en treatment duration
16 Use of psychotropic’s
18 Course of earlier treatments: drop-out, degree of improvement
39 Psychopathology in relatives
71 Severe somatic problems which can interfere with treatment
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Figure 2.2. Concept map of eight clusters of patient characteristics.
Table 2.2. Mean Importance of the Clusters and t-Test results for Differences in Importance 
between the Clusters.
Clusters (1) (2) (3) (4) (5) (6) (7) (8)
1. Severity of symptoms (4.26) -2.08 0.15 -2.21 4.32** 6.07** 7.40** 0.83
2. Severity of PD pathology . (4.47) 1.38 -0.29 5.01** 8.62** 7.83** 3.00*
3. Ego-adaptive capacities . . (4.24) -4.06** 3.42* 4.57** 5.61** 0.60
4.  Motivation and working 
alliance
. . . (4.53) 5.74** 5.94** 6.27** 1.88
5. Social context . . . . (3.81) 2.46 3.03* -1.82
6.  Social demographic 
characteristics
. . . . . (3.48) 1,71 -5.95**
7. Trauma . . . . . . (3.20) -4.34**
8.  Treatment history and 
medical condition
. . . . . . . (4.12)
Note. On the diagonal the averaged importance according to the participants (n = 18) of the 
clusters are presented. In the above diagonal elements the t-statistics are presented with df = 17, 
and the significance level. We used the Bonferonni correction for multiple testing resulting in 
more strict significance levels:
* p<0.01 ** p<0.0018.
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ing of the personality. It was judged to be a general indicator of the severity of 
the personality pathology. The cluster contains psychodynamic concepts such as 
focality of the personality pathology (28), but also diagnostic criteria according 
to the DSM-IV such as number of PDs and/or number of maladaptive personality 
traits (4), or type of PD (45).
The third cluster was named Ego-adaptive capacities, and consists of psycho-
dynamically oriented concepts such as identity integration (44), primitive defence 
mechanisms (42) and attachment pattern (33). One of the participants described 
this cluster as follows: “Ego-adaptive capacities refer to internal processes that 
mediate between the demands of the internal world and the external world, such 
as controlling internal impulses or meeting requirements of the outside world.” 
Although conceptually related the participants pointed to an important difference 
between the clusters Severity of personality pathology and Ego-adaptive capaci-
ties, Severity of personality pathology describes a general indication of the sever-
ity of the personality pathology, while Ego-adaptive capacities describes specific 
conflicts and/or deficiencies in the PD patient.
The fourth cluster was named Motivation and working alliance, and contains 
patient characteristics such as a high level of problem recognition (75), intro-
spective and reflective capacities (20), and therapy allegiance (69). There was 
relatively low consensus on the interpretation of this cluster, perhaps as a result 
of relatively low homogeneity within this cluster and relatively high relatedness to 
other clusters (high cluster bridging value, see Table 2.1). According to the experts 
‘motivation for treatment’ refers to some degree of positive outcome expectancy 
due to treatment, and to the effort patients are willing to invest in the demands of 
treatment (in terms of time, money, psychological effort). Working alliance refers 
to the patient’s capacity to form trusting bonds. Both concepts are considered to 
be mutually reinforcing.
Clusters five and six were named Social context and Social demographic char-
acteristics. Although conceptually related, the participants pointed to important 
differences between these two: whereas the cluster Social demographic character-
istic consists of factual information (e.g. age (17), gender (40), living conditions 
(55), and financial state of affairs (56)), the cluster Social context represents the 
patient’s effort and capacities to function socially (e.g. quality of the social network 
or support system (5), meaningful daily activities (26)).
Cluster seven was named Trauma. It is a conceptually uniform cluster (low 
cluster bridging value, see Table 2.1), and to the experts, the content of this cluster 
appeared to refer to traumas and emotional neglect in the present and/or past. 
The information appeared to be not only factual, but there also seems to be infor-
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mation about the perception of the patient. Patient characteristics belonging to this 
cluster are, for instance, history of being bullied (43), parental divorce in infancy 
(67), and continuing and/or actual traumatic circumstances (47).
The eighth and final cluster was named Treatment history and medical condi-
tion. It consisted of heterogeneous patient characteristics, as is evident from the 
high cluster bridging value (see Table 2.1). The experts described it as follows: 
“treatment history in terms of: kind of treatment, duration of treatment and the final 
treatment effect and medical conditions which can interfere with treatment.”
According to the experts, the concept map in Figure 2.2 appeared to reveal 
two underlying dimensions or axes. One axis ranges from cluster Severity of 
personality pathology to Social demographic characteristics. Clusters in the lower 
right corner are internal structures or processes in the patient, whereas clusters 
in the high left corner are external variables, e.g. situational and environmental 
characteristics. This axis is therefore called the internal – external axis. The other 
axis runs orthogonal to the previous axis, i.e. it moves from the cluster Treatment 
history and medical conditions towards the space between the two clusters Social 
context and Motivation and working alliance. Participants argued that in the lower 
left corner Vulnerability clusters are depicted that may be associated with slower 
change processes. In the upper right corner Strength clusters are depicted, that are 
often considered predictors for favorable treatment outcome, and a relative quick 
recovery. Hence this axis is called the vulnerability – strength axis.
DiscUssion
Drawing on clinical expertise and a literature review, we used the concept map 
method to summarize and describe patient characteristics pertinent to treatment 
selection for patients with personality disorders. We started out with a comprehen-
sive set of 81 patient characteristics deemed potentially relevant for such decisions. 
Using sorting and rating assignments and statistical techniques, a concept map 
emerged that reduced the total number of patient characteristics to eight meaning-
ful clusters. This final concept map had a satisfactory fit (stress = 0.22), adequate 
reliability, and yielded the following set of clusters of patient characteristics: (1) 
Severity of symptoms, (2) Severity of personality pathology, (3) Ego-adaptive 
capacities, (4) Motivation and working alliance, (5) Social context, (6) Social 
demographic characteristics, (7) Trauma, and (8) Treatment history and medical 
condition.
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The two bipolar dimensions underlying the eight clusters of patient character-
istics, i.e. internal versus external and strength versus vulnerability, suggest that 
there are at least two major criteria to be considered when selecting empirically 
based treatments for PD patients. First, the patient should be examined in terms 
of the amount of emotional pressure or stress she/he can tolerate (dimension 
vulnerability-strength). Possibly, this dimension may help decide whether the 
patient needs a primarily stabilizing or supportive treatment or, alternatively, may 
profit more from a primarily destabilizing or confrontational/expressive treatment. 
The concept of the supportive-expressive continuum is often used to describe dif-
ferent psychodynamic interventions, and is empirically based on the data of the 
Psychotherapy Research Project of the Menninger Foundation (Wallerstein, 1989). 
Expressive therapy is primarily focused at relational and conflict issues, and is 
targeted toward enhancing the patient’s cognitive and emotional understanding 
of his or her symptoms (Leichsenring & Leibing, 2007; Winston, 2003). In sup-
portive therapies, the establishment of a helping alliance is regarded as a central 
component and the treatment is directed toward improving stability of the patient’s 
psychological structure, a sense of self, and relationships (Leichsenring & Leib-
ing, 2007; Winston, 2003). Hypothetically, the distinction between supportive/
stabilizing or expressive/destabilizing can describe different psychotherapies for 
personality disorders. For example, dialectial behavior therapy (Linehan, 1993) 
can be classified as a relatively supportive and stabilizing treatment because of its 
highly structured program that emphasizes teaching specific skills and its focus on 
motivational factors, empathy, validation and active therapeutic support. Transfer-
ence focused psychotherapy (Yeomans, Clarkin, & Kernberg, 2002), on the other 
hand, might be categorized as relatively expressive and destabilizing as it uses 
more confrontational techniques (e.g. analysis of the transference), and provides 
less support when stress levels are increased or self-destructive behaviors have to 
be managed by the patient him/herself. A viable hypothesis for further research 
would be that more vulnerable patients are better off in supportive/stabilizing 
treatments, whereas patients with more strength characteristics benefit more 
from expressive/destabilizing treatments. This reasoning is in line with Gabbard 
(2005), who suggests that indicators for an expressive psychotherapy are char-
acteristics such as a strong motivation to understand, and good impulse control, 
while indicators for a supportive therapy are characteristics such as chronic ego 
weakness. The second bipolar dimension, i.e. external versus internal, may sug-
gest that it is worthwhile to examine whether the interventions should be primarily 
focused on systemic problems, such as family problems or lack of social support, 
or individual problems, such as mental states and symptoms. Whether these con-
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jectured patient-treatment matches translate to enhanced treatment outcomes may 
be investigated in further research, e.g. in match-mismatch designs.
The selected patient characteristics were considered of differential importance 
to the experts. Severity of symptoms, Severity of personality pathology, Ego-
adaptive capacities and Motivation and working alliance were considered of 
higher importance than the characteristics Social context, Social demographic 
characteristics and Trauma. These results are consistent with an earlier study 
focusing on the relationship between pre-treatment patient characteristics and the 
final treatment allocation in a PD patient population (Van Manen, et al., 2011). 
This study revealed several patient characteristics to be associated with treatment 
allocation, i.e. symptom distress, cluster C personality pathology, level of identity 
integration, motivation, treatment history, parental responsibility, and age. The 
similarities in patient characteristics between the present and earlier study under-
line the potential value for the treatment selection process of patient characteristics 
such as Severity of symptoms, Severity of personality pathology, Ego-adaptive 
capacities, and Motivation and working alliance. However, one difference be-
tween both studies is remarkable. According to the experts in the present study, 
Social context and Social demographic variables are less important, while in the 
earlier study a social demographic variable, i.e. having parental responsibility for 
children, was the strongest predictor of actual treatment allocation in daily prac-
tice. These contradicting results may be explained by the tendency of clinicians to 
underestimate the influence of practical variables, such as driving distance to the 
treatment center, insurance status, or work and family situations.
In this program of research, which aims at developing algorithms for treatment 
selection in a PD population, several further empirical studies are to be considered. 
First, to derive starting values (i.e. weights) for the specification of an actuarial 
treatment allocation algorithm, one might inspect existing datasets to derive post-
hoc matching relations between the clusters of patient characteristics, treatment 
allocation, and subsequent treatment outcome. Of note, the clusters need not to 
have the same status in the algorithm. While some of the patient characteristics 
appear to be crucial ingredients to case formulation (e.g. Severity of personality 
pathology, Ego-adaptive capacities and Motivation and working alliance), other 
characteristics (e.g. Social demographic characteristics) appear more like screen-
ers that a priori constrain the available options for selection. Second, one might 
prospectively test the treatment utility of such an actuarial algorithm by randomly 
assigning patients to either the algorithm or treatment selection as usual.
A major strength of this study was the systematic step-by-step procedure of the 
concept elicitation procedure as well as the relatively high number of participants 
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in the concept map procedure. However, our analysis also has several limitations. 
First, the current solution is representative for the Dutch situation in mental health 
care, which is characterized by a wide variety and availability of modalities of 
psychotherapy. For example, in the Netherlands long-term outpatient, day hospi-
tal, and inpatient psychotherapies are still reimbursed by insurance companies, 
whereas in many other countries they are not. Thus, it is recommended to try to 
replicate this study in other countries. Second, the concept map method depends 
on clinician self-report in retrospect, thereby possibly introducing pre-existing theo-
retical notions or beliefs rather than empirical facts. Therefore, our results should 
be regarded as a first step toward empirically based treatment selection. Clearly, 
further research is needed to investigate to what extent use of the presented con-
cepts yields more effective treatment selection.
In conclusion, this study revealed eight clusters of patient characteristics and 
two overarching dimensions deemed useful for selecting optimal psychotherapeu-
tic treatments for patients with PD. The found patient characteristics can serve as 
input for research on treatment selection algorithms, and their effectiveness, which 
may bring empirically based treatment selection for PD patients one step closer.
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abstract
Treatment selection in clinical practice is a poorly understood, often largely implicit 
decision process, perhaps especially for patients with personality disorders. This 
study therefore investigated how intake clinicians use information about patient 
characteristics to select psychotherapeutic treatment for patients with personality 
disorders. A structured interview with a forced choice format was administered 
to 27 experienced intake clinicians working in five specialist mental health care 
institutes in the Netherlands. Substantial consensus was evident among intake clini-
cians. The results revealed that none of the presented patient characteristics were 
deemed relevant for the selection of the suitable treatment setting. The appropriate 
duration and intensity are selected using severity or personal strength variables. 
The theoretical orientation is selected by using personal strength variables.
Van Manen, J.G., Kamphuis, J.H., Visbach, G.T., Ziegler, U.M., Gerritsen, A., 
Van Rossum, G., Rijnierse, P.M., Timman, R., & Verheul, R. (2008). How do intake 
clinicians use patient characteristics to select treatments for patients with personal-
ity disorders? Psychotherapy Research, 18(6), 711-718.
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introDUction
Recent systematic review studies have concluded that psychotherapy is an effica-
cious treatment for patients with personality disorders, with mean effect sizes rang-
ing between approximately 1.0 and 2.5 for various outcome parameters (Bateman 
& Fonagy, 1999; Leichsenring & Leibing, 2003; Perry, Banon & Ianni, 1999). 
To date, however, there is no conclusive evidence for the superiority of specific 
psychotherapeutic treatments in the treatment of personality disorders. Whereas 
some studies suggest that cognitive-behavioral psychotherapies are more effective 
than psychodynamic psychotherapies for borderline (Giesen-Bloo et al., 2006) 
and avoidant (Emmelkamp et al., 2006) personality disorder, other studies have 
reported equal benefit from those two theoretical orientations (Leichsenring & Leib-
ing, 2003; Svartberg, Stiles & Seltzer, 2004). Furthermore, the available studies 
did not examine the differential effectiveness of various dosages of psychotherapy 
in terms of setting, duration or intensity of treatment.
Effectiveness of treatment would likely substantially benefit from evidence-based 
treatment selection strategies. Currently, there is only a modest evidence base for 
these strategies (Links & Stockwell, 2001; Vervaeke & Emmelkamp, 1998). In fact, 
several studies have indicated that treatment selection is instead (partly) guided by 
non-evidence based factors such as the availability of treatment facilities (Chiesa, 
Bateman, Wilberg, & Friis, 2002; Issakidis & Andrews, 2003), personal experi-
ence and strong belief (or faith; Beutler, 2000; Vervaeke & Emmelkamp, 1998), 
and socio-demographical variables (e.g., employment status, health insurance 
status; Scheidt et al., 2003). This situation likely results in an inefficient usage of 
the available resources. Furthermore, treatment selection based on these rationales 
can be non-effective or even harmful (Beutler, 2000).
Several researchers have attempted to provide guidelines for treatment selec-
tion using innovative review procedures. Particularly important among these is 
the effort by the group of experts headed by Castonguay and Beutler (2006). 
Critchfield and Smith Benjamin (2006) describe a set of principles for therapeutic 
change in patients with personality disorders. One of these principles is that 
patient- and problem-related factors are linked to outcome in personality disorder 
treatment. They note, for example, that the match between level of impairment and 
treatment intensity is important in treatment selection. It should be noted, however, 
that the status of these principles is somewhat preliminary because they are largely 
based on findings from other disorders and are generalized based on the subjec-
tive sense that the results may be salient to personality disorders as well. Indeed, 
they recognize that these principles, at present, should be considered ‘reasonable 
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hypotheses.’ In sum, it can be concluded that the development of clinical decision 
models for systematic application of the stepped and matched care principles is 
in its infancy.
The present study aims to elucidate how intake clinicians use pre-selected pa-
tients characteristics to determine optimal treatment parameters for patients with 
personality disorders, and to what extent they agree on these allocation strategies. 
More specifically, this study explores a) to what extent intake clinicians agree 
about matching key patient characteristics to selected macro treatment character-
istics (i.e., setting, duration, intensity, and theoretical orientation), and b) what the 
nature of these consensus reports of perceived matching relations is.
methoD
Participants
Twenty-seven clinicians (21 licensed psychotherapists and six psychiatrists) were 
recruited from five different mental health care institutes (i.e., Center of Psycho-
therapy De Viersprong, Halsteren, n = 8; Altrecht, Zeist, n = 4; Zaans Medical 
Center, Zaandam, n = 5; Center of Psychotherapy De Gelderse Roos, Lunteren, 
n = 6; Center of Psychotherapy Mentrum, Amsterdam, n = 4). These institutes offer 
a representative sample of outpatient, day hospital and inpatient psychotherapeu-
tic programs for patients with personality problems and/or personality disorders 
in the Netherlands. All clinicians were involved in the intake procedure of their 
institute. The entire sample had considerable clinical experience (i.e. a median of 
19 years of clinical experience; range = 5-35 years). All intake clinicians were 
familiar with multiple theoretical orientations, including cognitive-behavioral, 
psychodynamic and experiential psychotherapy. Seventeen of the total of 27 
intake clinicians indicated that they were primarily psychodynamically trained, 
three received primarily cognitive behavioral training, four indicated extensive 
psychodynamic and cognitive behavioral training, and three received primarily 
experiential training.
Selection of patient characteristics
To determine the most important patient characteristics, a list of relevant patient 
characteristics for treatment selection was derived from the literature. In a review 
study of outcome predictors in group psychotherapy, Piper (1994) reported that 
treatment outcome of therapy could be predicted by the interaction between 
patient characteristics and form of therapy. Predictive patient characteristics 
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included internal locus of control, psychological mindedness, motivation, social 
competence, learned resourcefulness, ego strength, coping style, and defense 
style. Another review study on the characteristics of patients who do well in time-
limited psychotherapies revealed that severity of disturbance, motivation, capacity 
to relate, ego strength, psychological mindedness, focality, and response to trial 
therapy are important factors influencing treatment outcome (Lambert & Ander-
son, 1996). Furthermore, Beutler, Alomohamed, Moleiro and Romanelli (2002) 
reported six patient and problem variables that have been found to relate either 
to patient prognosis or to moderate different types of treatments; functional impair-
ment, subjective distress, social support, complexity/ comorbidity, resistance, and 
coping skills. Other studies found similar patient characteristics to be important 
when allocating patients to treatment (Rosenbaum, Selzer, Valbak, Hougaard, & 
Sommerlund, 1997; Tillett, 1996; Truant, 1999).
A list of 18 somewhat overlapping patient characteristics resulted. To reduce 
overlap and to obtain a manageable set of patient characteristics, we asked a 
group of 29 intake clinicians from the participating institutes to select the six most 
relevant patient characteristics for allocating patients to treatments. Finally, Janine 
van Manen and Roel Verheul served as an expert panel to reduce redundancy 
and decide on the final set. The resulting set of 12 patient characteristics were: 
ego strength, motivation for change, psychological mindedness, capacity for a 
therapeutic relation, quality of defense style, capacity to relate, symptom severity, 
type of personality disorder, treatment history, focality of problem(s), having a job, 
and care responsibility.
To facilitate the matching task for the interviewees, patient characteristics were 
dichotomized into high versus low ‘severity’ levels. With regard to type of person-
ality disorder, two dummy variables were created (i.e. Cluster A versus Cluster BC, 
and Cluster AB versus Cluster C; these dummy variables were thought to reflect the 
severity hierarchy between the clusters (e.g., Cluster A has more severe pathology 
than Cluster B, and Cluster B has more severe pathology than Cluster C). The 
‘treatment history’ Variable was dichotomized into outpatient versus day hospital/ 
inpatient treatment because these levels differ most in terms of (financial) costs.
Defining of treatment parameters
A subsequent task was to select the most relevant treatment parameters. We focused 
on ‘macro-treatment’ decisions (i.e., broad decisions about the general treatment 
model that is likely to be most effective and efficient; Livesley, 2003; Sanderson 
& Clarkin, 2002; Verheul, 2005). The characteristics focused on in this study are 
(a) the optimal treatment setting, (b) the necessary duration, (c) the appropriate 
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intensity of treatment (i.e., the use of confrontational/expressive techniques as 
opposed to supportive strategies), and (d) the most suitable theoretical orientation. 
For each of these four treatment parameters high-dosage and low-dosage levels 
were specified.
Setting
We distinguished between outpatient and day hospital/inpatient psychotherapies. 
A low dosage refers to outpatient psychotherapy and a high dosage reflects day 
hospital/inpatient psychotherapy.
Duration
Short-term and long-term psychotherapies were contrasted. Because psychotherapy 
for patients with personality disorders might require up to 200 sessions or more 
(Perry et al., 1999), a relatively high cut-off point was chosen. Short-term treat-
ments were defined as day hospital or inpatient psychotherapies shorter than half 
a year, or outpatient psychotherapies with less than 50 sessions (i.e., low dosage); 
long-term treatments were defined as day hospital or inpatient psychotherapies of 
half a year or longer, or outpatient psychotherapies with 50 sessions or more (i.e., 
high dosage).
Intensity
In line with Gabbard (2000), we distinguished between supportive and con-
frontational treatments. Gabbard describes a continuum on which different 
psychotherapeutic interventions can be placed. One extreme consists of expres-
sive (confrontational) forms of treatment which turn unconscious conflicts into 
consciousness through therapist confrontations, interpretations, and clarifications. 
The other extreme includes supportive psychotherapy, which aims at suppressing 
unconscious conflicts and instead bolstering defenses by therapist empathetic 
validation, advice giving, and praise of appropriate behavior (Gabbard, 2000). 
A low dosage refers to a supportive psychotherapy, and a high dosage refers to 
a confrontational psychotherapy.
Theoretical orientation
The majority of treatments use different interventions at different moments in time. 
Nevertheless, most therapies can be classified according to the predominant set 
of interventions during treatment (Gabbard, 2000). Psychodynamic and cognitive-
behavioral therapies are the most frequently applied theoretical orientations in 
the treatment of personality disorders (Leichsenring, & Leibing, 2003), and were 
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therefore chosen as the focus of our study. Regarding theoretical orientation, the 
coding into dosage levels was less appropriate; the purpose remained, however, 
to examine matching relations with patient characteristics. Cognitive behavioral 
treatment was therefore arbitrarily assigned the low dose while psychodynamic 
received the high dose coding.
Assessment procedure
A structured interview was designed to investigate agreement among intake clini-
cians about the possibilities for matched care. Janine van Manen conducted all 
27 interviews. Each intake clinician was interviewed about the potential match-
ing relation between 12 patient characteristics and four treatment parameters 
(i.e., setting, duration, intensity, and theoretical orientation). To illustrate, for the 
potential matching relationship between psychological mindedness and duration, 
for instance, the clinician was asked: “Which duration (short-term or long-term) 
is indicated among patients with low [or high] psychological mindedness?” The 
intake clinician might for example answer: “A patient with low psychological 
mindedness is indicated for a long-term psychotherapeutic treatment, whereas 
a patient with high psychological mindedness is indicated for a short-term psy-
chotherapeutic treatment.” Intake clinicians were instructed to focus only on (a) 
patients with a personality disorder, (b) patients who do not meet exclusion criteria 
for psychotherapy (e.g., brain damage, mental retardation, or schizophrenia), 
and (c) a situation without any local, financial or managerial restrictions to treat-
ment availability. For each patient characteristic level, intake clinicians chose 
either of the dosage levels, or had the option to answer ‘I don’t know/ All options 
are feasible’ (these two possibilities were taken together because they are both 
indicative of a non-matching relation).
As shown in Table 3.1, there are nine possible response patterns. Patterns a, b 
and c are referred to as ‘Matching 1’, i.e. fully or partially consistent with a match 
between high severity and high dosage, or a match between low severity and low 
dosage:
- Pattern a: A ‘full matching’ pattern (i.e. fully consistent with the matches just 
described);
- Pattern b: A ‘partial matching’ pattern: the high-severity level is indicative for a 
high dosage, but the low-severity level does not match with a particular dosage 
level;
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- Pattern c: Also a ‘partial matching’ pattern, but the reverse of Pattern b: the 
low-severity level is indicative for a low dosage, but the high-severity level is 
not indicative for a certain dosage level.
Patterns d, e, and f are consistent with the reverse of ‘Matching 1’, and are 
referred to as ‘Matching 2’ (i.e. fully or partially consistent with a match between 
high severity and low dosage or between low severity and high dosage:
- Pattern d: A ‘full matching’ pattern (i.e. fully consistent with the pattern just 
described);
- Pattern e: A ‘partial matching’ pattern: the high-severity level is indicative for a 
low dosage, but the low-severity level does not match with a particular dosage 
level;
- Pattern f: Also a ‘partial matching’ pattern, but the reverse of Pattern e: the 
low-severity level is indicative of a high dosage, but the high-severity level is 
not indicative of a certain dosage level.
Patterns g, h and i are not indicative for matching, and consist of the following 
three options:
- Pattern g: Applicable when the interviewee is unable to select an appropriate 
dosage level for high-severity and low-severity patients;
- Pattern h: Indicates that the high treatment dosage is indicated for both severity 
levels;
- Pattern i: Indicates the opposite of Pattern h (i.e. both severity levels are indica-
tive of the low treatment dosage).
Statistical procedures
Each of the nine patterns (a-i) was assigned a value between  –2 and 2 (see 
Table 3.1). Matching 1 patterns were assigned a positive value: The full matching 
pattern (a) was assigned a score of 2, and the partial matching patterns (b) and c) 
were assigned a score of 1. Matching 2 patterns were assigned a negative value: 
The full matching pattern (d) was assigned a score of -2, and the partial matching 
patterns (e) and (f) were assigned a score of -1. All remaining patterns were not 
indicative for matching, and were assigned a score of 0.
Forty-eight potential matching patterns were assessed in the interview (i.e., 
12 patient characteristics x 4 treatment parameters) and coded into a score 
between –2 and 2 according to the algorithm described previously. To narrow 
it down to those patient characteristics that intake clinicians deemed relevant for 
macro treatment decisions, we selected only the matching patterns for which 70% 
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or more of the participants agreed that there was a matching relation (i.e., = 30% 
or less indicated a value of 0 to the matching relation). To test the null hypothesis 
that the answers of the intake clinicians are indicative of a non-matching relation 
(value = 0), we subsequently conducted non-parametric Mann-Whitney tests.
resUlts
Table 3.2 shows to what extent clinicians agree that patient’s characteristics are 
useful in determining the most appropriate setting, duration, intensity, and theo-
retical orientation in personality-disordered patients. Percentages are provided 
for each of the possible matching patterns (i.e., Matching 1 [full, and partial], 
Matching 2 [full, and partial], and no match), as well as the test statistic (Mann-
Whitney U).
Matching to Treatment Setting
Based on Table 3.2 none of the selected patient characteristics were deemed rele-
vant for the selection of treatment setting, according to at least 40% (range = 40.7 
- 81.5%) of the intake clinicians.
Matching to Treatment Duration
Our findings indicate that focality and ego strength were deemed relevant by 
clinicians for determining treatment duration. Focality is the strongest potential 
Table 3.1. All possible scores for a matching relation between patient characteristic and treat-
ment parameter
Matching relation: Matching 1 Matching 2 No Matching
Potential answers: (a) (b) (c) (d) (e) (f) (g) (h) (i)
Severity level: Dosage level:
High severity level Low-dosage level 0 0 99 1 1 99 99 0 1
High-dosage level 1 1 99 0 0 99 99 1 0
Low severity-level Low-dosage level 1 99 1 0 99 0 99 0 1
High-dosage level 0 99 0 1 99 1 99 1 0
Score 2 1 1 -2 -1 -1 0 0 0
Note: 0 means that the interviewee indicates that the dosage level does not apply for the specific 
severity level; 1 means that the interviewee indicates that the dosage level applies for the specific 
severity level; 99 means that the interviewee indicates that both dosage levels are applicable or 
that he/she doesn’t know
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matching variable; half of the intake clinicians agreed that patients with focal 
problems benefit from short-term psychotherapy, whereas broad spectrum prob-
lems require long-term psychotherapy (U = 65.0, p < .001). Furthermore, there is 
substantial agreement that patients with high ego strength might benefit sufficiently 
from short-term psychotherapy.
Matching to Treatment Intensity
The results indicate that more than half of the patient characteristics were deemed 
relevant by clinicians for determining the appropriate treatment intensity. For 
example, 85.2% of the clinicians agree that patients with low ego strength should 
Table 3.2. Matching relations between patient characteristics and treatment parameter (N=27)
Matching pattern Matching 
pattern 1
Matching 
pattern 2
No Match Mann-Whitney 
Test
Score
Full
2
Partial
1
Full
-2
Partial
-1 0 U
% % % % %
Setting parameters
None
Duration parameters
Focal or broad problem(s) 50.0 30.8 0.0 0.0 19.2 65.0***
Ego strength 33.3 33.3 0.0 3.7 29.6 135.0**
Intensity parameters
Symptom severity 0.0 0.0 44.4 29.6 25.9 94.5***
Type personality disorder1
 Cluster A vs BC 0.0 0.0  3.7 74.1  22.2  81.0*** 
Ego strength 0.0 0.0 85.2 14.8 0.0 0.0***
Psychological mindedness 0.0 0.0 74.1 14.8 11.1 40.5***
Capacity to relate 0.0 0.0 63.0 14.8 22.2 81.0***
Quality of defense 
mechanism
0.0 0.0 70.4 14.8 14.8 54.0***
Capacity for a therapeutic 
relation
0.0 0.0 55.6 25.9 18.5 67.5***
Theoretical orientation
Ego strength 0.0 3.7 29.6 40.7 25.9 121.5***
Psychological mindedness 0.0 0.0 48.1 29.6 22.2 81.0***
*p<0.05, **p<0.01, ***p<0.001
1Cluster A includes paranoid, schizoid, and schizotypal personality disorder; cluster B includes 
borderline, antisocial, narcissistic, and histrionic personality disorder; cluster C includes dependent, 
avoidant, and obsessive-compulsive personality disorder.
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be assigned to supportive psychotherapy, whereas those with high ego strength 
would benefit most from confrontational psychotherapy. Similar findings apply 
to psychological mindedness, capacity to relate, quality of defense style, and 
capacity for a therapeutic relationship. Furthermore, 74.1% of the intake clinicians 
agreed that supportive psychotherapy is indicated for Cluster A patients. One 
intake clinician also agreed that a confrontational approach was indicated for 
Cluster BC patients. Patients with high symptom severity are, according to the 
intake clinicians, best treated with a supportive psychotherapy, and/or patients 
with few symptoms are best treated with a confrontational /expressive approach 
(U = 94.5, p < .001).
Matching to Theoretical Orientation
Based on Table 3.2, according to 77.7% of the intake clinicians psychologically 
minded patients are likely to benefit more from psychodynamic psychotherapy, 
and 48.1% of intake clinicians agreed also that their low-scoring counterparts are 
more likely to benefit from cognitive behavioral treatments (U = 81.0, p < .001). 
The majority of the intake clinicians (70.3%) agreed that patients with high ego 
strength could benefit from psychodynamic treatment. Furthermore a minority 
(29.6%) indicated that patients with low ego strength would benefit most from a 
cognitive behavioral treatment.
DiscUssion
In this study we investigated, using a forced-choice format interview, (a) the ex-
tent to which experienced intake clinicians involved in the care of patients with 
personality disorders, agreed on matching relations between pre-selected patient 
characteristics and macro treatment parameters, and (b) the substance of those 
agreed upon principles. Generally, the appropriate duration and intensity are 
selected using severity variables or personal strength variables, and the theoretical 
orientation is selected using personal strength variables.
There was little consensus on treatment setting. Less then 70% of the intake 
clinicians could affirm any matching relation between the presented patient 
characteristics and treatment setting. The intake clinicians apparently use differ-
ent patient characteristics when selecting the appropriate setting, or other factors 
may guide intake clinicians’ selection of treatment setting (see e.g. Klein, Menza, 
Arfken, & Schuster, 2002 for alternative treatment allocation criteria for patients 
with substance use problems). Our conjecture is that the patient preference counts 
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heavily when selecting the appropriate setting, especially when potential day 
hospital or inpatient treatment programs are involved, because these choices have 
a major impact on the patient’s daily life (work, family). This hypothesis is in line 
with a literature review of Van Audenhove and Vertommen (2000) who stressed 
the importance of patient preferences in determining treatment choice.
There are hints that the preferred matching relations do not necessarily reflect 
the state of research. For example, Clarkin, Levy, Lenzenweger and Kernberg 
(2007) and Levy and colleagues et al. (2006) concluded that severe borderline 
patients profit from highly structured outpatient psychotherapy with a confronta-
tional approach (transference focused psychotherapy). Our results, on the other 
hand, suggest that intake clinicians assign patients with a high severity level and 
patients with less personal strengths to psychotherapy with a supportive approach, 
in which unconscious conflicts are suppressed rather than clarified or made con-
scious. Perhaps intake clinicians did not incorporate recent empirical evidence in 
their decision making.
Ego strength was deemed relevant for the selection of optimal levels of dura-
tion, intensity, and theoretical orientation. Our findings indicate that patients who 
lack ego strength are deemed more suitable for long-term, supportive psycho-
therapies, whereas their relatively strong counterparts are referred to short-term, 
confrontational psychotherapies. This selection strategy fits with evidence from 
several studies that reported high drop-out rates for patients with severe personal-
ity disorders in short-term, psychodynamic day hospital psychotherapy, especially 
antisocial, schizotypal, or borderline personality disorder (Vaglum et al., 1990; 
Wilberg et al., 1998). Especially for these groups of patients, long-term programs 
emphasizing supportive elements and/or structured skills training are more likely 
to be successful than short-term programs stressing expressive and interpretive 
elements. This selection strategy is also consistent with the success of mentalization 
based treatment (MBT) for patients with severe personality disorders (Bateman & 
Fonagy, 1999; 2001). MBT can be characterized as a highly structured program 
emphasizing supportive elements and spreading the confrontational components 
over a long period of time.
Ego strength, psychological mindedness, capacity to relate, quality of defense 
mechanisms, and capacity for a therapeutic relation showed an essentially 
identical pattern of association with decisions regarding the appropriate intensity 
of treatment. Intake clinicians might take all these variables into consideration 
when selecting the most appropriate intensity. Other possible explanations for the 
multiple matching relations are that (a) intake clinicians may not have been able 
to differentiate between these parameters at a conceptual level, and (b) the respec-
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tive strength parameters may be strongly interrelated, and perhaps may even refer 
to a single underlying construct. Further research may clarify the interrelations 
among the various patient characteristics, and may examine their differential utility 
for matching purposes.
Our findings should be interpreted with some caution. First, dichotomization 
of the patient characteristics assumes a linear association with the treatment pa-
rameters, but in reality the relationship might be non-linear (e.g., both extremely 
low-severity and extremely high-severity patients might be indicated for outpatient 
treatment, whereas those in between might be indicated for day hospital/inpa-
tient treatment). This concern is somewhat mitigated by the fact that we identified 
considerable agreement among clinicians about possibilities for matched care, 
whereas a nonlinear relationship would most likely occur in case of disagreement 
among clinicians. Nevertheless, non-linear alternatives should be recognized in 
further work on this topic. Second, the current report is limited to single-factor 
matching associations, whereas in reality patient characteristics might interact 
so that the impact of a characteristic is contingent on different levels of another 
variable. In fact, we attempted to elicit this kind of information from the intake 
clinicians, but the internal representation and reasoning in terms of interactions 
quickly become too complex to yield reliable evaluations. Third, despite our care-
ful consideration and extensive consultation with expert clinicians, the selection 
of patient characteristics remains open for debate. A systematic literature review 
on predictors of treatment outcome in patients with personality disorder may yield 
alternative patient characteristics that are of potential relevance for treatment 
selection. The same goes for the somewhat arbitrary cut-off points for each of the 
treatment and patient parameters. For different settings, different cut-offs may work 
better. Furthermore the intake clinicians might interpret the high and low levels of 
the respective patient characteristics differently, resulting in low agreement among 
clinicians. Scales might describe the patient characteristics more accurately.
These limitations notwithstanding, the present study has demonstrate that expert 
clinicians show a substantial level of consensus on patient characteristics that are 
relevant when selecting the appropriate duration, intensity and theoretical orienta-
tion of a psychotherapeutic treatment. This study explicates treatment allocation 
strategies and as such opens the ‘black box’ of clinical judgment in treatment 
selection. However, the present findings are certainly not meant in a prescriptive 
sense: They reflect consensus appraisals of experienced clinicians, when using a 
forced choice format and carefully selected dichotomized patient and treatment 
parameters. As such, the present study provides testable hypotheses for treatment 
selection research. Do clinicians in fact refer patients with personality pathology 
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according to these (or other) strategies, and do these (or other) strategies in fact 
promote treatment outcome? These questions should be elaborated on in future 
studies.
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abstract
Within a large multi-center study in patients with personality disorders, we inves-
tigated the relationship between patient characteristics and treatment allocation. 
Personality pathology, symptom distress, treatment history, motivational factors, 
and sociodemographics were measured at intake in 923 patients, who subse-
quently enrolled in short-term or long-term outpatient, day hospital, or inpatient 
psychotherapy for personality pathology. Logistic regressions were used to ex-
amine the predictors of allocation decisions. We found a moderate relationship 
(R2 = 0.36) between patient characteristics and treatment setting, and a weak 
relationship (R2 = 0.18) between patient characteristics and treatment duration. 
The most prominent predictors for setting were: symptom distress, cluster C per-
sonality pathology, level of identity integration, treatment history, motivation, and 
parental responsibility. For duration the most prominent predictor was age. We 
conclude from this study that, in addition to pathology and motivation factors, 
sociodemographics and treatment history are related to treatment allocation in 
clinical practice.
Van Manen, J.G., Andrea, H., Van den Eijnden, E., Meerman, A.M.M.A., Thun-
nissen, M.M., Hamers, E.F.M., Huson, N., Ziegler, U., Stijnen, T., Busschbach, 
J.J.V., Timman, R., & Verheul, R. (2011). Relationship between patient character-
istics and treatment allocation for patients with personality disorders. Journal of 
Personality Disorders, 25(5), 656-657.
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introDUction
Psychotherapy has shown to be an effective treatment for patients with personality 
disorders (PD; Bateman & Fonagy, 2000; Binks, et al., 2006; Leichsenring & 
Leibing, 2003; Perry, Banon, & Ianni, 1999). This is true for a variety of dosages 
and theoretical orientations (Verheul & Herbrink, 2007). No single approach has 
yet been proven to be superior to another (Bateman & Fonagy, 2000; Benjamin & 
Karpiak, 2002). In everyday practice, a clinician will need to select a therapy that 
fits not only the patient’s diagnosis and other clinical characteristics but is also ac-
cepted by the patient and fits in with his or her practical circumstances (Norcross, 
2002a). The underlying hypothesis is that a good fit between patient and treatment 
will increase the effectiveness of treatment. In practice, patient-treatment matching 
is typically based on clinical judgments, as empirically validated predictors that 
specify which patient will benefit most from which treatment are undeveloped 
(Spinhoven, Giesen-Bloo, van Dyck, & Arntz, 2008).
Given the absence of sound empirical evidence, Castonguay and Beutler 
(2006) formulated their ‘principles of change’ that provide knowledge and 
guidelines for selecting and fitting therapeutic procedures (Castonguay & Beutler, 
2006). The principles are presented for four frequently encountered disorders, 
including personality disorders. An example of a principle of change relevant for 
treatment selection in PD patients is: “more severe problems require more time in 
treatment or more types of treatment in order to facilitate change” (Critchfield & 
Benjamin, 2006). It should be acknowledged that most evidence presented by 
Critchfield & Benjamin is tentatively generalized from psychotherapy research into 
other mental disorders to PD (Critchfield & Benjamin, 2006).
Another line of research related to treatment selection is research on modera-
tors of treatment outcome in PD. Accumulating evidence points to the important 
role of the therapeutic alliance. For example, in a review on the role of the 
therapeutic relationship in effective treatments of PD patients, the available data 
suggests that effectiveness is associated with a good therapeutic alliance and with 
the therapist’s willingness to set limits, usually through therapy rules or contracts 
(Benjamin & Karpiak, 2002; Smith, Barrett, Benjamin, & Barber, 2006). However, 
how these findings can be translated into treatment allocation rules is not yet 
clear. For example, the effect of setting limits in treatment may depend on (1) the 
theoretical orientation of treatment, (2) the clinical characteristics of the PD patient 
and (3) therapist factors (Smith, et al., 2006).
In addition to empirical evidence, clinical expertise is recognized as an im-
portant factor for optimizing treatment allocation (Spengler, et al., 2009; Zeldow, 
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2009). Spinhoven (2008) showed for instance that assessors can accurately 
predict treatment outcome in a population of borderline patients (Spinhoven, et 
al., 2008). In line herewith, we assume that clinical expertise can be used as a 
preliminary source of information for optimal treatment allocation. In this study, we 
tried to describe the variation in treatment allocation on the basis of measurable 
characteristics of patients with PD. The aim is to provide insight in the clinical 
expertise used in treatment allocation. This insight into clinical expertise can be 
used directly to improve treatment allocation, or it can be used to formalize test-
able hypotheses for empirical research.
More specifically, we will report on the association between various patient 
characteristics and subsequent treatment allocation in terms of setting (outpatient, 
day hospital, or inpatient) and treatment duration (short-term, or long-term). To the 
best of our knowledge this is the first large study to investigate treatment selection 
in PD patients over a broad range of psychotherapeutic treatments.
methoD
Intake Procedure
Subjects participated in the large-scale, multi-site Study on the Cost-Effectiveness of 
Personality Disorder Treatments (SCEPTRE; Bartak, et al., 2010) and were recruited 
from consecutive admissions to six mental health care centers in the Netherlands 
(i.e., De Viersprong, Halsteren; Altrecht, Utrecht; Zaans Medisch Centrum, Zaan-
dam; De Gelderse Roos, Lunteren; Mentrum, Amsterdam; GGZ WNB, Bergen op 
Zoom/Roosendaal). These centers offer outpatient, day hospital, and/or inpatient 
psychotherapy for adult patients with personality pathology. Subsequent to referral 
and before the start of the intake procedure, all applicants performed a battery 
of paper and pencil assessments at home. The battery included self-report ques-
tionnaires measuring psychopathology, personality, functional impairments and 
treatment history (see Measurement Instruments). In addition, the intake procedure 
took one or two assessment sessions with an intake clinician in which the following 
topics could be discussed with the patient: anamnesis, medication, somatic prob-
lems, treatment history, biographic information, living situation, examination of 
psychological functions, testing the limits, treatment motivation and preferences, et 
cetera. The intake procedure also included a semi-structured interview for diagnos-
ing personality disorders (SIDP-IV, see Measurements Instruments) conducted by 
an independent clinician. Intake clinicians had access to the individual scores on 
the questionnaires and the semistructured interview. After the assessment sessions, 
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the intake clinicians had a routine meeting with the intake team to discuss the 
treatment selection. This treatment selection was then discussed with the patient in 
a session. When patients were allocated to treatment, patients provided informed 
consent. The current study design was approved by the Dutch Medical Ethics 
Committee.
Study population
From March 2003 to March 2006, 1380 patients completed the intake procedure 
and were selected for treatment. Of those, 155 (11%) patients did not meet the 
inclusion criteria, i.e., age between 18-70 (n=13), significant personality pa-
thology (n=34), intention of the referral was psychotherapy aimed at changing 
maladaptive personality patterns; if the treatment was focused on axis I, for ex-
ample alcohol dependency or severe eating disorder, patients were not included 
(n=99), sufficient command of the Dutch language (n=6), absence of organic 
cerebral impairment (n=1), no mental retardation (n=1), and no schizophrenia 
(n=1), leaving 1225 patients eligible for the study. In addition, 100 patients (8%) 
refused to participate, 31 patients (3%) were not able to participate due to logistic 
reasons (e.g. no appointment could be made for providing informed consent), 38 
patients (3%) dropped out of treatment prematurely (did not enter treatment or had 
less than three treatment sessions/hospital days), and 133 patients (11%) were 
excluded due to missing or unreliable assessment data. Of the remaining 923 
patients, 115 (12%) had no PD diagnosis. However, the majority of these patients 
(70%) scored positively on at least five PD criteria. As these patients can also be 
characterized as a group with a relevant level of personality pathology (Verheul, 
Bartak, & Widiger, 2007), all 115 patients were included in the study population.
Treatment allocation
The six mental health care centers offer various psychotherapeutic treatments 
tailored to a PD population. In this study we clustered these different treatments 
in terms of setting and duration. We opted to look first at setting and duration 
given that they have a profound influence on treatment costs and cost-effectiveness 
(Soeteman, et al., 2010; Soeteman, et al., 2011). With respect to setting, pa-
tients were either referred to (1) outpatient psychotherapy, up to a maximum of 
two sessions per week (n=272; 29%), (2) day hospital psychotherapy, at least 
one morning/afternoon per week, mostly combined with psychosocial treatment 
(n=311; 34%) or (3) inpatient psychotherapy, patients staying and sleeping at 
the institution five days a week, receiving different forms of psychotherapeutic 
and psychosocial treatment (n=340; 37%). Short-term treatment was limited to 
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treatment durations up to 6 months (n=350, 38%), whereas long-term treatment in-
cluded treatments with durations of 6 months and longer (n=573, 62%). Table 4.1 
shows the descriptives for the total study population.
Measurement instruments
The patient characteristics can be divided into five categories: sociodemograph-
ics, treatment history, symptom distress, motivation for treatment, and severity level 
of personality pathology. Sociodemographics included: sex, age, educational 
level (medium/high, i.e., at least intermediate vocational education or secondary 
school), parental responsibility (i.e., responsibility for caring for children), and 
having a job (i.e., retired, having work or studying). Treatment history refers to 
outpatient and inpatient treatment history as two (not mutually exclusive) catego-
ries. Symptom distress was measured using the Global Severity Index (GSI), as 
measured by the Dutch SCL-90-R (Arrindell & Ettema, 1981; Derogatis, 1977). 
High scores indicate more distress. Motivation for treatment was measured using 
the total score of the Motivation for Treatment Questionnaire (MTQ; van Beek 
& Verheul, 2008). High scores refer to a high level of motivation. Personality 
pathology was measured by a semi-structured interview and two questionnaires. 
PDs were assessed using the Dutch version of the Structured Interview of DSM-IV 
Personality Disorders (SIDP-IV; de Jong, Derks, van Oel, & Rinne, 1995; Pfohl, 
Blum, & Zimmerman, 1995). This interview included the 11 formal DSM-IV-TR Axis 
II diagnoses, including PD Not Otherwise Specified (PDNOS), two appendix di-
agnoses (i.e., depressive and negativistic PD) and self-defeating PD. The reliability 
of the instrument in this study was moderate to high (Bartak, et al., 2010). To form 
mutually exclusive diagnostic groups, we clustered the formal DSM-IV-TR Axis II di-
agnoses hierarchically into: cluster A (at least one cluster A PD present; paranoid, 
schizoid, or schizotypal PD); cluster B (at least one cluster B PD present; antisocial, 
borderline, histrionic, or narcissistic PD, but no cluster A PD) and cluster C (at least 
one cluster C PD present; avoidant, dependent, or obsessive-compulsive PD, but no 
cluster A or B PD). As a measure of the severity of personality pathology, we used 
the five higher-order domains of the Severity Indices of Personality Pathology (SIPP-
118): self-control, identity integration, responsibility, relational functioning, social 
concordance (Verheul, et al., 2008). Higher scores reflect a more adaptive level 
of personality functioning. Defensive functioning was measured by the Overall 
Defensive Functioning (ODF) score derived from the Defensive Style Questionnaire 
(Trijsburg, van ‘t Spijker, Van, Hesselink, & Duivenvoorden, 2000). Higher scores 
refer to more mature levels of defensive functioning.
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Statistical analyses
Logistic regression models were performed in order to determine the effect of each 
patient characteristic on the treatment allocation. When setting (inpatient, day 
hospital, outpatient) was the outcome, a multinomial logistic regression analysis 
was conducted, yielding 3 comparisons; (1) inpatient versus outpatient, (2) day 
hospital versus outpatient, and (3) inpatient versus a day hospital setting. For 
the model with duration as the outcome variable, a binary logistic regression 
analysis was performed, with short-term treatment as a reference category. In 
these models, all patient characteristics were entered simultaneously. We could 
not find evidence for multicollinearity. Odds Ratios (OR) with accompanying 
95% confidence intervals were computed for each patient characteristic, together 
with the percentage of explained variance of the entire model, as measured by 
Nagelkerke’s (proxy) R2 (Nagelkerke, 1991). In all models, continuous predictors 
were divided by their standard deviation. This facilitates the interpretation of the 
ORs of different questionnaires, with each point of the OR score being equivalent 
to one standard deviation (in stead of one point on the scale). Patients with incom-
plete data were excluded from the analyses. Statistical analyses were performed 
with SPSS 15.0.1.
resUlts
Table 4.2 shows the ORs and corresponding 95% confidence intervals resulting 
from logistic regression analyses with either setting or duration as outcome.
Allocation to treatment setting
With respect to setting, the complete model could explain a moderate level of 
variance (Nagelkerke’s R2 = 0.36). Almost all patient characteristics were related 
to treatment setting. Significant predictors for an inpatient treatment setting as 
opposed to an outpatient treatment setting were: medium/high education, no 
parental responsibilities, an outpatient treatment history, higher level of symptom 
distress, higher level of motivation, lower level of identity integration, lower level of 
responsibility, and a more mature level of defensive functioning. Significant predic-
tors for a day hospital setting as opposed to outpatient treatment were: medium/
high education, no parental responsibility, an outpatient treatment history, higher 
level of symptom distress, higher level of motivation, cluster C PD pathology, lower 
level of responsibility and a more mature level of defensive functioning. Significant 
predictors for inpatient treatment as opposed to day hospital treatment were: male 
Chapter 4
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gender, no parental responsibilities, higher motivation for treatment, absence of 
cluster A/B/C PD, higher level of self control, and a lower level of identity integra-
tion.
Allocation to treatment duration
With respect to duration, the complete model explained less variance compared 
to setting: Nagelkerke’s R2 was 0.18. It seems that the preselected patient char-
acteristics cannot predict accurately whether a patient is allocated to a short-term 
or long-term therapy. Age was found to be a significant predictor, indicating that 
older patients were significantly less likely to be selected for long-term treatment 
(OR = 0.62; CI = 0.52-0.75; p < 0.001). Furthermore, lower educational level, 
lower level of motivation, cluster B pathology, and a less mature defense style are 
associated with long-term treatment.
DiscUssion
In a large sample of PD patients, we found that many patient characteristics under 
study were associated with treatment selection in terms of setting and duration. 
This finding seems to support the view that treatment selection is a multifactorial 
decision process (Tillett, 1996; Valbak, 2004). Prominent predictors for setting 
were: educational level, parental responsibility, treatment history, symptom dis-
tress, motivation, cluster C PD, level of identity integration, level of responsibility, 
and level of defensive functioning. In addition, age and cluster B PD were found 
to be prominent predictors for treatment duration.
The preselected patient characteristics explained a moderate amount of vari-
ance in the model for setting (36%), and a relatively small amount of variance 
in the model for duration (18%). The small amount of explained variance in the 
duration model could be explained by treatment heterogeneity in both the short 
and long treatment group. For example, short inpatient treatment differs consider-
ably from short outpatient treatment in its capacity to provide containment in a 
“pressure cooker” atmosphere (Chiesa, Fonagy, & Gordon, 2009). An alternative 
explanation for the relatively low amount of explained variance in the duration 
model is the cautiousness of intake clinicians in setting (time) limits on the treat-
ments and their preference for open-ended treatments (Yeomans, Seber & Clarkin, 
1992).
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Allocation to treatment setting
With respect to treatment setting, the results suggest a relationship between 
severity of pathology and treatment setting. Patients at the two extreme ends of 
the personality pathology spectrum (i.e., high versus low severity) seem to be 
preferably allocated to an outpatient treatment, whereas patients in the middle 
of the spectrum are more often selected for a day hospital or inpatient treatment. 
This finding is consistent with clinical expertise that considers high severity patients 
to be at risk of being destabilized by the high levels of affect arousal originating 
from the intensity that is typical for many day hospital and inpatient treatments. 
Furthermore, their healthy counterparts, with less deficit pathology and more focal 
problems, are typically assumed to be able to profit sufficiently from less intensive 
treatment. For these reasons, both patient groups are more likely to be selected 
for treatments in an outpatient setting. On the contrary, patients with moderately 
severe personality pathology who also have some healthy aspects (e.g. high 
motivation, high responsibility) are considered to profit most from intensive day 
hospital or inpatient treatment, as they are more capable of tolerating the arousal 
levels resulting from such treatments.
Our data showed that an outpatient treatment history predicted assignment 
to a day hospital and inpatient treatment. This finding can be understood from a 
stepped care perspective, i.e. to start with a lower and cheaper treatment dosage 
when possible, and step up to a higher and more expensive treatment dosage 
when necessary (Bower & Gilbody, 2005). Intake clinicians apparently use this 
principle in daily practice.
In addition to personality pathology and treatment history, the results showed 
that ‘practical’ patient characteristics, especially having parental responsibilities, 
were associated with treatment allocation. These findings are not surprising: 
earlier studies reported that practical variables such as availability of local treat-
ment facilities, insurance status, and employment status had a significant influence 
on treatment allocation (Chiesa, Bateman, Wilberg & Friis, 2002; Issakidis & 
Andrews, 2003; Scheidt, Burger, & Strukely, 2003).
Allocation to treatment duration
With respect to the length of the treatments, our data showed that older patients 
were more likely to be selected for short-term treatment. It could be hypothesized 
that patients with more severe and persistent pathology will seek treatment at an 
earlier age, whereas those who can cope without treatment for a longer period of 
time are typically patients with less severe problems. Furthermore, we observed 
a tendency for patients with more severe pathology and less adaptive capacities, 
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especially cluster B patients, to be selected for longer treatment. This treatment 
selection tendency is in line with the research of Chiesa and colleagues who found 
in a sample of cluster B patients that longer treatment predicted positive outcome 
(Chiesa & Fonagy, 2007).
Limitations
The main strengths of the current study include the inclusion of a large number 
of patients, the multi-center design including treatment centers offering various 
settings and durations of psychotherapy, and the presence of an extensive as-
sessment battery at intake. However, the study also had some limitations. First, it 
should be noted that the generalizibility of our findings may be limited to countries 
such as The Netherlands that have the availability of day hospital and inpatient 
psychotherapy facilities. Second, we did not take into account all possible determi-
nants for treatment allocation. Other determinants might be: clinician preferences 
or theoretical orientation (Witteman & Koele, 1999), patient-therapist relationship 
factors (Norcross, 2002b) and local availability of treatment facilities (Chiesa, 
et al., 2002; Issakiis & Andrews, 2003; van Audenhove & Vertommen, 2000). 
Third, even after careful consideration, the operationalization of the patient 
characteristics remains open for debate. Fourth, we did not consider interactions 
between patient characteristics. It could therefore be that some characteristics are 
differently associated to treatment allocation under certain circumstances. Fifth, 
we focused only on setting and duration, and not on the theoretical orientation 
of treatment. Obviously a similar study with a focus on theoretical orientation of 
treatment would be interesting.
In conclusion, this study showed that, in addition to pathology and motivation 
descriptors, sociodemographics and treatment history are also related to treatment 
allocation in clinical practice. Whether the associations identified in this study 
are truly relevant for optimizing the (cost)effectiveness of treatment remains to be 
seen: do variations in treatment allocations indeed make a difference in relation 
to treatment outcome? We therefore recommend that future studies should test 
matching hypotheses in this regard.
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Tailoring psychotherapy in patients 
with personality disorders: matching 
the level of psychological strengths 
to the level of stabilizing versus 
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abstract
Clinical evidence suggests that patients high on psychological strengths profit more 
from destabilizing psychotherapy, whereas patients low on strengths profit more 
from stabilizing psychotherapy. This matching hypothesis was tested. This quasi-
experimental study was conducted between 2003 and 2008 in 735 patients with 
personality disorders from 6 psychotherapy centers in the Netherlands. Patients 
were assigned to different levels of stabilizing and destabilizing psychotherapies. 
Levels of psychological strengths were measured. We used multilevel modeling to 
estimate outcome at 12 months after baseline. The propensity score controlled for 
initial differences at baseline. The findings show that destabilizing psychotherapies 
have slightly better outcomes than stabilizing psychotherapies. Patients high on 
psychological strengths improve slightly more than patients low on psychological 
strengths. The observed interaction effect contradicted our hypothesis. The results 
imply that destabilizing psychotherapies can be considered as first treatment op-
tion for patients both high and low on psychological strengths.
Van Manen, J.G., Horn, E.K., Stijnen, T., Busschbach, J.J.V., & Verheul, R. (2014). 
Tailoring psychotherapy in patients with personality disorders: matching the level 
of psychological strengths to the level of stabilizing versus destabilizing psycho-
therapy. Personality and Mental Health, 9, 133-149.
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introDUction
Personality disorders (PDs) are highly prevalent mental disorders with high indi-
vidual, societal and economic burden of disease (Soeteman, Hakkaart-van Roijen, 
Verheul, & Busschbach, 2008; Soeteman, Verheul, & Busschbach, 2008). Although 
PDs are relatively enduring conditions, amenability to psychological treatments 
has been established and documented (APA, 2001; Binks, et al., 2006; Leich-
senring & Leibing, 2003; Perry, Banon, & Ianni, 1999). Importantly, the efficacy 
of psychotherapy for PD is not primarily determined by the specific theoretical 
orientation, but rather by the consistent application of a coherent and – both to 
patient and to therapist – comprehensible therapeutic method (Verheul & Herbrink, 
2007). In addition, efficacious treatments are typically characterized by a high 
level of structure, effort to enhance compliance, a clear focus, a long-term and 
powerful attachment relationship, an active stance, and integration with other 
services (Bateman & Fonagy, 2000).
An element that has received less attention but is nevertheless likely to be 
essential, is the optimal level of destabilizing in treatment. Patients with PD are 
typically characterized by persistent and pervasive patterns of cognition, emotion 
and behavior. From a dynamic systems theory perspective, it can be predicted that 
such patterns or ‘attractor states’ need to be destabilized first. Then more functional 
patterns can be organized (Hayes & Strauss, 1998; Thelen & Smith, 1994). This 
prediction is in line with the principles of psychodynamic psychotherapy promot-
ing the application of various interpretive or expressive techniques (Gabbard, 
2005). Such techniques are focused on uncovering unconscious wishes, fears, 
conflicts and defenses, as opposed to supportive techniques that help the patients 
to adapt to stresses while avoiding insights. The broad spectrum of psychothera-
peutic techniques can be placed on an expressive-supportive continuum, running 
from typically expressive or destabilizing categories such as interpretation and 
confrontation to typically supportive or stabilizing categories such as empathic 
validation, advice and praise, and affirmation (Horwitz, et al., 1996). Psychody-
namic psychotherapy explicitly encourages to “be as expressive as you can be, 
and as supportive as you have to be” (Wallerstein, 1986, p.688). In this study we 
defined three levels of destabilization. The focus in the ‘stabilizing treatments’ is 
on acceptance and help patients to cope with his PD problems. Therapists typically 
work with supportive and structuring interventions, which results in relatively low 
stress levels during treatment. The focus in the ‘destabilizing treatments’ is on 
change and help the patient to replace their dysfunctional patterns by adaptive 
ones. Therapists typically work with confrontative, expressive, insight-oriented 
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interventions, which results in relatively high stress levels during treatment. In the 
intermediate variant therapists focus simultaneously on acceptance and change, 
and use both stabilizing and destabilizing interventions, resulting in changing 
stress levels in the patient.
To the best of our knowledge we are not aware of any empirical study focus-
ing directly on the importance of stabilizing versus destabilizing in the treatment 
of PD. However, various studies provide pieces of evidence that are consistent 
with the psychodynamic literature which suggests that patients scoring high on 
psychological strengths or ego-adaptive capacities (e.g. capacity to relate, iden-
tity integration and the ability to mentalize) are better able to tolerate and profit 
from destabilizing techniques than patients scoring low on such psychological 
strengths. This ‘matching hypothesis’ is for instance supported by various studies 
that have shown that patients with severe PD drop out prematurely from expres-
sive psychotherapies more often than from supportive psychotherapies (Piper, 
Joyce, McCallum, & Azim, 1998; Piper, McCallum, Joyce, Azim, & Ogrodniczuk, 
1999). Secondly, the studies of Bartak and colleagues (2011; 2010) have shown 
superiority of short-term inpatient psychotherapy in patients with cluster C but not 
with cluster B PD. Short-term inpatient treatments are characterized by a high 
level of therapeutic intensity and pressure. The authors suggest that “patients with 
cluster C personality pathology might be able to handle the high pressure of this 
treatment modality better than (pure) cluster B PD patients, who probably have a 
lower tolerance for therapeutic pressure” (Bartak, et al., 2010, p. 28). Third and 
finally, the matching hypothesis is consistent with Gabbard’s (2000) suggestion 
of patient characteristics that can help clinicians decide whether a predominantly 
expressive versus a predominantly supportive treatment focus is indicated. Accord-
ing to Gabbard, indications for a highly expressive modality are, for instance: a 
strong motivation, suffering, tolerance of frustration, psychological mindedness, 
and intact reality testing, whereas indications for a highly supportive modality are, 
for instance: low anxiety tolerance, poor frustration tolerance, poor impulse con-
trol, and little capacity for self-observation. Some research in a non-PD population 
supports the suggestion of Gabbard of a matching relation, i.e. matching between 
level of personality organization (Koelen, et al., 2012) or different personality 
types (anaclictic/introjective) (Blatt, Zuroff, Hawley, & Auerbach, 2010) and type 
of intervention (interpretive versus supportive) (Piper, Joyce, McCallum, & Azim, 
1998; Piper, McCallum, Joyce, Azim, & Ogrodniczuk, 1999).
The present study aims to explore the matching hypothesis outlined above in 
a large quasi-experimental, naturalistic study. In this population we study whether 
patients high on strengths profit more from predominantly destabilizing treatments, 
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whereas patients low on strengths might profit more from predominantly stabiliz-
ing treatments. Research questions are focused on (1) the impact of psychological 
strengths on treatment outcome, (2) the impact of level of destabilization on treat-
ment outcome, and (3) the interaction between the patient’s psychological strength 
and the treatment’s level of destabilization with respect to outcome.
methoD
Participants
Participants (n = 735) were recruited from a consecutive series of admissions to 
six mental health care centers in the Netherlands (i.e. de Viersprong, Netherlands 
Institute for Personality Disorders, Halsteren; Altrecht, Utrecht; Zaans Medical 
Centre, Zaandam; Pro Persona, Centre of Psychotherapy, Lunteren; GGZWNB, 
Halsteren; Arkin, Amsterdam). These centers offer specialist psychotherapy for 
adult patients with PDs. From March 2003 to March 2006, a total of 1,379 
admissions completed the intake and screening procedure and were selected for 
treatment (Figure 5.1). The intake and screening procedure included self-report 
questionnaires and a semistructured interview for diagnosing PDs. The data 
obtained from this initial assessment served as baseline data for our study. As it 
was part of the standard screening procedure, and not involved additional risks 
or load, informed consent for the baseline data collection was not mandatory 
under Dutch law. The study was approved by the medical ethics committee of the 
Erasmus MC.
Of the 1,379 admissions, 146 were excluded from the study because of one of 
the following inclusion criteria: age between 18 and 70 years (n = 13), personal-
ity pathology is primary psychiatric disorder (not eating disorder for example) 
(n = 34), and referral for psychotherapeutic treatment aimed at personality prob-
lems (n = 99). Nine patients met one of the following exclusion criteria: insufficient 
command of the Dutch language (n = 6), organic cerebral impairment (n = 1), 
mental retardation (n = 1), and schizophrenia (n = 1).
This left 1,224 eligible patients, of whom 100 refused to participate (i.e., 
did not provide informed consent) and 38 patients did not enter treatment (i.e., 
received less than two treatment sessions or less than two days of inpatient or day-
hospital psychotherapy). Another 31 patients could not participate due to logistic 
reasons (i.e., no appointment could be made to provide informed consent), and 
134 patients were excluded due to missing or unreliable self-report questionnaires 
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or semi-structured interview (mostly because of lack of interviewers at the start of 
the study, n=106).
The remaining 921 patients were informed about the study and its procedures, 
provided written informed consent for follow up data, and entered the study. Of 
those, 186 were post hoc excluded because they could either not be diagnosed 
with a PD (n=115) or the follow-up data were not available (n=71). There was 
no difference in psychiatric symptoms (BSI), their social role and relational func-
tioning (OQ-45) , their level of personality pathology (SIPP-118) and the socio-
demographic variables age and sex at baseline between patients with follow-up 
data and those without. The final sample consisted of 735 patients who were 
included in this study.
Treatments and level of destabilization
Patients were assigned to the different psychotherapeutic treatments available in 
the six treatment centers in the local standard way, i.e. based on the available 
test results, expert opinion and clinical experience (for more information about the 
Do not comply with 
inclusion and exclusion 
criteria study (n=155)
Patients selected for 
treatment (n = 1379)
Refused to participate and 
other reasons (n=303)
Patients enrolled in 
treatment (n = 921)
No Personality Disorder 
diagnosis assessed with SIDP-
IV (n = 115)
No follow-up measurement 
(n = 95)
Patients analyzed 
(n  = 712)
Stabilizing treatment
N = 384
Destabilizing treatment
n =328
Figure 5.1. Patient flow
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local treatment selection: Van Manen, et al., 2008; Van Manen, et al., 2011; Van 
Manen, et al., 2012, in this thesis the articles can be found in chapter 2, 3 and 
4). Treatments were delivered by licensed psychiatrists of psychologists. They had 
an average of 15 years of postgraduate clinical experience (SD =10.1).
The available treatments differ in terms of setting (i.e. outpatient, day-hospital 
and inpatient), duration (i.e., varying from three to 24 months), theoretical orienta-
tion (predominantly cognitive-behavioral and psychodynamic orientations) and 
level of destabilization. The latter characteristic is focused on in this study. The 
level of destabilization of all individual treatment programs in the six treatment 
centers were scored on a 3-point Likert scale (i.e., low, intermediate, and high 
level) at two times during the investigation. In 2002 (before the inclusion started), 
the intake clinicians of each center provided a consensus rating for each treatment 
program. As we were interested in the reliability and validity of this measurement, 
we repeated the scoring procedure in 2007 (after the inclusion was completed), 
but this time we asked the managers in the steering committee of the investigation, 
to independently provide scores. Both times we instructed the respondents to score 
the level of destabilization independent from the setting and the duration of the 
treatment. The three levels were described as follows:
1. Low level of destabilization: Predominantly stabilizing psychotherapies focus 
on acceptance and help patients to cope with his PD problems. Therapists typi-
cally work with supportive and structuring interventions. Examples of therapeu-
tic techniques are: giving advice, psycho-education and empathic validation. 
As a result the tension or stress in the patient is kept as low as possible.
2. Intermediate level of destabilization: These psychotherapies focus simultane-
ously on acceptation of the PD problems as well as on helping patients to 
replace their dysfunctional patterns by adaptive ones. Therapists work both 
with confrontative, expressive, insight-oriented interventions and with sup-
portive and structuring interventions. Because of the flexibility in using both 
techniques, a therapist tailors his interventions to the tension and stress level 
of the patient, or by the psychic state of the patient at the specific moment in 
treatment.
3. High level of destabilization: Predominantly destabilizing psychotherapies 
focus on change and help the patient to replace their dysfunctional patterns 
by adaptive ones. Therapists typically work with confrontative, expressive, 
insight-oriented interventions aiming at uncovering unconscious wishes, fears, 
conflicts and defenses. Examples of therapeutic techniques are: interpretation, 
confrontation and clarification. As a result the tension and stress level in a 
patient can increase to a high level.
Chapter 5
86
The two measurements in 2002 and 2007 were highly correlated (r  =  .69, 
p< .001), supporting the reliability and construct validity of our operationalization 
of level of destabilization. In this study we used the level of destabilization scores 
by the managers in the steering committee of the investigation. Because only 36 
out of the 735 patients had a treatment with a low level of destabilization, we 
combined the low and intermediate level into a group with low level of destabiliza-
tion (referred to as ‘stabilizing psychotherapy’) and a group with high level of 
destabilization (referred to as ‘destabilizing psychotherapy’).
Assessments
PD diagnosis
DSM-IV-TR PD diagnoses were measured using the Dutch version of the Structured 
Interview for DSM-IV Personality Disorders (SIDP-IV) (Jong, Derks, Oel, & Rinne, 
1995; Pfohl, Blum, & Zimmerman, 1997). This interview covers the 11 formal 
DSM-IV-TR axis II diagnoses including PD not otherwise specified (PDNOS), two 
appendix diagnoses (i.e. depressive and negativistic PD), and self-defeating PD. 
Interviewers were Master level psychologists, who were trained thoroughly by one 
of the authors (R.V.). They received monthly booster sessions to avoid deviation 
from the interviewer guidelines. Inter-scorer reliability was evaluated in a conve-
nience sample of 25 videotaped interviews, that were rated by three observer 
raters resulting in 75 observations. Percentage of agreement between observer 
raters ranged from 84% (avoidant PD) to 100% (schizoid) (median 95%). Intra-
class correlation coefficients for the sum of DSM-IV PD traits present (i.e. scores ‘2’ 
or ‘3’) ranged from 0.60 (schizotypal) through 0.92 (antisocial) (median 0.74).
Strength measures
As there is no golden standard for measuring psychological strengths or ego-
adaptive capacities, we considered this variable a ‘latent construct’ and used 
four operationalizations: severity of PD, adaptive personality functioning, overall 
defensive functioning, and motivation for treatment. These variables fit into the 
internal-strength domain as revealed by a recent concept map study of patient 
characteristics relevant for treatment assignment (Van Manen, et al., 2012). First, 
severity of PD was measured with the SIDP-IV (describing of the administration 
is given above). To form mutually exclusive diagnostic groups, we clustered the 
formal DSM-IV-TR Axis II diagnoses hierarchically into: (a) Low strength group: at 
least one cluster A or B PD present (i.e., paranoid, schizoid, schizotypal, antiso-
cial, borderline, histrionic, and/or narcissistic PD) versus (b) High strength group: 
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at least one cluster C PD or PDNOS present (i.e., avoidant, dependent, obsessive-
compulsive, depressive, passive aggressive, and/or mixed PD, but no cluster A or 
B PD). Second, adaptive personality functioning was measured using the Severity 
Indices of Personality Pathology (SIPP-SF) (Verheul, et al., 2008). The SIPP-SF mea-
sures five domains of adaptive personality functioning; high scores reflect adaptive 
personality, whereas low scores reflect maladaptive personality. We computed a 
total score by adding all items and applied a median split to distinguish high from 
low adaptivity. Third, overall defensive functioning was measured using the Dutch 
version of the Defense Style Questionnaire (DSQ-60). The DSQ-60 is designed 
to measure type and degree of the defensive style (Bond, Gardner, Christian, & 
Sigal, 1983; Thygesen, Drapeau, Trijsburg, Lecours, & de Roten, 2008), high 
scores reflect a more mature level of defensive functioning, whereas low scores 
reflect less mature level of defensive functioning. We applied a median split on 
the Overall Defensive Functioning (ODF) score, to form (a) a relatively mature 
group versus (b) a relatively immature group. Finally, motivation for treatment was 
measured using the 8-item Motivation for Treatment Questionnaire (MTQ) (Van 
Beek & Verheul, 2008). The MTQ consists of two subscales, i.e., Need for help 
and Readiness to change; high scores reflect high level of motivation, whereas low 
scores reflect a low level of motivation. A median split was applied on the total 
score of the 8 items and distinguishes high from low motivation.
Outcome Measures
The primary outcome measures were psychiatric symptoms and psychosocial func-
tioning. Psychiatric symptoms were measured using the Dutch version of the Brief 
Symptom Inventory (BSI) (De Beurs & Zitman, 2006; Derogatis & Melisaratos, 
1983), a validated self-report scale derived from the revised Symptom Checklist-90 
(SCL-90-R) (Arrindell & Ettema, 2003; Derogatis, 1986). In this study, we used the 
Global Severity Index (GSI) as the mean score of the 53 BSI items. The GSI ranges 
from 0-4, with higher scores indicating more problems. Psychosocial functioning 
was measured with two subscales of the Outcome Questionnaire-45 (OQ-45), 
i.e. Interpersonal relations and Social role functioning (Lambert, et al., 1996). 
The subscale Interpersonal relations ranges from 0-44, the subschale Social role 
functioning ranges from 0-36, with higher scores indicating more problems. All 
three outcome measures were assessed at baseline and several follow-up points. 
Three treatment centers conducted follow-ups at approximately 12, 24, and 36 
months after baseline; the other three treatment centers conducted follow-ups at 
the end of treatment, subsequently after about 6 and 12 months, and again at 36 
months after baseline. The use of different assessment points was due to logistic 
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reasons and was taken into account by choosing multilevel modeling as the statisti-
cal method for the analyses.
Statistical Analyses
Baseline differences between stabilizing groups were analyzed with t-tests for 
normally distributed variables, Mann-Whitney U tests for non-normal distributed 
variables and continuity corrected chi² tests for categorical variables.
We used multilevel modeling to deal with the dependency of repeated measures 
on the same subject in time and longitudinal data with observations unequally 
spaced in time. First, we estimated the uncorrected treatment effect at 12 months 
after baseline using a random intercept and random slope model with time as level 
I and patient number as level II. Within-group effect sizes (Cohen’s d) (Cohen, 
1988) were calculated to describe changes from baseline to 12 months for each 
treatment group. Second, we estimated the treatment effects at 12 months cor-
rected for baseline differences by means of the ‘propensity score’ (for a detailed 
description of this method and its use in psychotherapy research, see Bartak et al., 
(2009) and Spreeuwenberg (2010). Using the propensity score, we attempt to 
‘mimic’ random assignment (as in a randomized clinical trial) to psychotherapies 
with high and low levels of ‘destabilization’. To identify relevant confounders to be 
used to calculate the propensity score, we considered a list of social and economic 
variables. All variables significantly related to a specific outcome were used to 
estimate the univariate propensity scores in a regression analysis, with group 
membership (high versus low levels of destabilization) as a dependent variable. 
Diagnostic variables likely to be correlated with the psychological strengths, and 
the psychological strength variables themselves were not included in the propen-
sity score, as including those would decrease the sensitivity of our design and 
diminish effects. To compare change in outcome variables across the treatment 
groups, a sophisticated multilevel model was used. Dependent variables were the 
change scores (follow up minus baseline) as observed during follow-up for each 
of the outcome measures. The following independent variables were entered in the 
model: time, outcome measure at baseline, the propensity score, group member-
ship (high or low level of destabilization), the patient strength characteristic and 
the interaction between group membership and patient strength characteristic. 
This model estimated differences in change scores at 12 months after baseline 
between the two treatment groups.
All analyses were based on intention-to-treat (ITT). ITT is defined as assignment 
and a minimal exposure to the intended treatment modality. All patients completed 
at least one follow-up assessment, and received a ‘minimally effective dosage’ of 
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psychotherapy (defined as at least two sessions of outpatient psychotherapy or 
at least two treatment days of day hospital or inpatient psychotherapy). The ITT 
analyses are based on the initial treatment assignment and not on the treatment 
eventually received. Drop-out and crossover between treatments are possible. 
However, dropout rage seems quite manageable; the proportion of dropout were 
12.9% in destabilizing treatments and 19.5% in stabilizing treatments. Further-
more 79.2 percent of patients received the treatment setting they were allocated 
to. The analyses were performed using SPSS 21 for data preparation and baseline 
differences. Proc Mixed of SAS 9.3 was applied for multilevel modeling (SAS 
Institute Inc., Cary, N.C., USA).
resUlts
Sample characteristics
Of the 735 patients, 69.9% were female, and 30.1% male. The mean age was 
33.7 years (SD = 9.7). Education was medium to high for 73.6% of the patients. 
Furthermore, 22.9% of the sample had a parental responsibility. The percentage 
of patients without a job was 35.2%. The percentage of patients that were married 
was 21.1%. In terms of PD diagnoses, 8.2% had a cluster A PD, and an additional 
24.9% had a cluster B (but no cluster A) PD. Thus, 33.1% of the patients had a 
cluster A and/or B PD, constituting the ‘low strength’ group. Furthermore, 38.9% 
had a cluster C (but no cluster A and/or B) PD, and an additional 28.0% had a 
PDNOS (but no cluster A, B, and/or C) PD. Thus, 66.9% of the patients had a 
cluster C PD and/or PDNOS, constituting the ‘high strength’ group.
Treatment characteristics
Table 5.1 shows that the average length of the destabilizing psychotherapies is 
somewhat shorter (7.6 ± 4.8 months) than of stabilizing psychotherapies (11.7 
± 5.3 months). Furthermore, destabilizing psychotherapies are more likely to be 
executed in an inpatient setting than stabilizing psychotherapies (55.1% versus 
25.4%), whereas stabilizing psychotherapies are more likely to be executed in 
a day-hospital setting (39.4% versus 30.2%) or outpatient setting (35.2% versus 
14.7%) than destabilizing psychotherapies. Higher mean scores for the strength 
operationalizations DSQ-odf, SIDP-IV and MTQ-total were observed for the de-
stabilizing group. No baseline differences were found for the outcome variables.
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Table 5.1. Socio-demographics, diagnostic and treatment characteristics of all 735 patients and of 
the patients in the two different psychotherapies
Total 
population
Destabilizing
psychotherapy
Stabilizing
psychotherapy
p-value
N 735 334 401
Socio-demographics
 Sex (% female) 69.9 64.4 74.6 0.004
 Age (mean years ± SD) 33.7 (9.7) 34.7 (10.0) 32.8 (9.3) 0.008
 Medium/high education (%) 73.6 77.5 70.3 0.027
 Parental responsibility (%) 22.9 21.3 24.4 0.375
 Unemployed (%) 35.2 33.2 39.9 0.337
 Marital situation
  Never married (%) 67.5 67.4 67.6 0.120
  Married (%) 21.1 23.7 19.0 0.057
  Widowed or divorced (%) 11.4 9.0 13.5 0.950
Diagnostics a
 Cluster A (%) 8.2 8.1 8.2 1.000
 Cluster B (%) 24.9 19.5 29.4 0.002
 Cluster C (%) 38.9 43.3 35.2 0.027
 Cluster NAO (%) 28.0 29.0 27.2 0.634
Strength operationalizations
 SIPP: total 2.6 (0.4) 2.6 (0.4) 2.6 (0.4) 0.168
 DSQ: odf 3.6 (0.4) 3.7 (0.4) 3.6 (0.4) 0.006
 SIDP-IV: AB vs CNOS (%) 38.9 43.4 35.2 0.027
 MTQ: total 59.1 (8.5) 59.8 (7.8) 58.4 (8.9) 0.027
Outcome variables
 GSI 1.5 (0.7) 1.5 (0.6) 1.6 (0.7) 0.619
 OQ-45 Interpersonal Relations 21.2 (6.2) 21.2 (6.0) 21.3 (6.3) 0.792
 OQ-45 Social Role 15.6 (4.8) 15.8 (4.7) 15.5 (4.9) 0.473
Treatment characteristics
 Duration (mean months ± SD) 9.8 (5.5) 7.6 (4.8) 11.7 (5.3) <0.001
 Outpatient (%) 25.9 14.7 35.2 <0.001
 Day-hospital (%) 35.2 30.2 39.4 0.009
 Inpatient (%) 38.9 55.1 25.4 <0.001
Drop-out rate (%) 16.5 12.9 19.5 0.022
a Assessed with the SIDP-IV, a semi-structured interview for DSM-IV axis II diagnoses. Hierarchically 
ordered: cluster A (at least one cluster A PD present); cluster B (at least one cluster B PD present, but no 
cluster A PD), cluster C (at least one cluster C PD present, but no cluster A or B PD) and cluster NAO 
(at least one mixed or appendix PD present, but no cluster A,B or C PD).
SIPP=Severity Indices of Personality Pathology, DSQ: odf=Overall Defensive Functioning scale of the 
Defense Style Questionnaire, SIDP-IV: cluster AB vs CNOS=hierarchically clustered PD groups mea-
sured with the Structured Interview for DSM-IV Personality Disorders, MTQ=Motivation for Treatment 
Questionnaire, GSI=Global Severity Index of the Brief Symptom Inventory, OQ-45=Outcome question-
naire-45
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Uncorrected outcome
Table  5.2 shows the uncorrected effect sizes for patients with low versus high 
psychological strengths, both in stabilizing and destabilizing psychotherapies, for 
each outcome variable and strength operationalization separately. One year after 
treatment all patients in destabilizing as well as in stabilizing psychotherapies 
showed improvements in terms of psychiatric symptoms, social role, and relational 
functioning (Table 5.2). Remarkably, we can observe a consistent pattern in the 
data, with substantially greater effect sizes in patients with low strengths (effect 
sizes range 0.8-2.0, median 1.3) than in those with high strengths (effect sizes 
range 0.0-1.0, median 0.5), both across outcome variables, levels of destabiliza-
tion and across strength dichotomies (i.e., severity of PD, adaptive personality 
functioning, and overall defensive functioning), but not for motivation for treatment. 
With respect to motivation for treatment, we can observe a reversed pattern, with 
substantially greater effect sizes in patients with high motivation (effect sizes range 
1.1-1.9, median 1.2) than in those with low motivation (effect sizes range 0.4-0.6, 
median 0.5), both across outcome variables and levels of destabilization.
Table 5.2. Uncorrected mean outcomes (SD) and effect sizes in the four patient-psychotherapy 
groups for all outcome variables estimated at 12 months after baseline
 
 
Outcome
Patient’s strenght 
operationalizationsb
Patient-psychotherapy groupsa
Stabilizing psychotherapy Destabilizing psychotherapy
Low strenghtsb High strenghtsb Low strenghtsb High strenghtsb
GSI SIPP: total Baseline 1.90 (0.65) 1.20 (0.52) 1.82 (0.55) 1.27 (0.53)
    12 months 0.61 (0.72) 0.96 (0.62) 0.74 (0.80) 1.09 (0.60)
    ES 1.98 0.47 1.96 0.35
    n 200 195 158 169
  DSQ: odf Baseline 1.84 (0.67) 1.21 (0.52) 1.77 (0.56) 1.33 (0.57)
    12 months 0.65 (0.73) 0.88 (0.64) 0.76 (0.78) 1.06 (0.65)
    ES 1.76 0.61 1.79 0.48
    n 220 178 151 182
  SIDP-IV:
cluster AB
vs CNOS
 
Baseline 1.80 (0.73) 1.41 (0.62) 1.61 (0.62) 1.50 (0.60)
  12 months 0.79 (0.72) 0.78 (0.68) 0.86 (0.81) 0.93 (0.68
  ES 1.38 1.02 1.22 0.95
  n 149 249 92 241
  MTQ: total Baseline 1.33 (0.63) 1.79 (0.66) 1.38 (0.64) 1.68 (0.52)
    12 months 0.95 (0.69) 0.63 (0.66) 1.09 (0.63) 0.70 (0.78)
    ES 0.59 1.75 0.45 1.87
    n 202 190 162 170
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Table 5.2. Uncorrected mean outcomes (SD) and effect sizes in the four patient-psychotherapy groups for all out-
come variables estimated at 12 months after baseline (continued)
 
 
Outcome
Patient’s strenght 
operationalizationsb
Patient-psychotherapy groupsa
Stabilizing psychotherapy Destabilizing psychotherapy
Low strenghtsb High strenghtsb Low strenghtsb High strenghtsb
OQ-45: 
Interpersonal
relations
SIPP: total Baseline 24.30 (5.34) 18.18 (5.71) 23.98 (4.95) 18.43 (5.72)
  12 months 14.21 (7.28) 17.95 (6.76) 15.54 (7.45) 17.86 (6.99)
  ES 1.89 0.04 1.71 0.10
    n 143 241 90 238
  DSQ: odf Baseline 23.46 (5.93) 18.59 (5.70) 23.37 (5.55) 19.30 (5.77)
    12 months 14.87 (7.75) 16.98 (6.77) 15.93 (7.20) 17.39 (7.40)
    ES 1.45 0.28 1.34 0.33
    n 220 179 152 181
  SIDP-IV:
cluster AB
vs CNOS
Baseline 22.78 (6.37) 20.38 (6.10) 21.53 (5.59) 21.02 (6.17)
  12 months 16.13 (7.95) 16.04 (7.04) 16.87 (7.31) 16.48 (7.34)
  ES 1.04 0.71 0.83 0.74
  n 149 250 91 242
  MTQ: total Baseline 20.30 (6.34) 22.33 (6.08) 20.18 (6.05) 22.09 (5.84)
    12 months 17.03 (7.02) 15.17 (7.40) 17.44 (7.28) 15.73 (7.29)
    ES 0.52 1.18 0.45 1.09
    n 202 191 162 171
OQ-45: Social 
role 
SIPP: total Baseline 16.95 (4.75) 14.07 (4.67) 17.21 (4.57) 14.49 (4.37)
  12 months 10.90 (5.76) 12.34 (5.07) 11.17 (6.32) 12.86 (5.63)
  ES 1.27 0.37 1.32 0.37
    n 195 188 155 166
  DSQ: odf Baseline 16.65 (4.95) 14.14 (4.52) 17.18 (4.53) 14.63 (4.46)
    12 months 11.07 (5.93) 12.03 (5.08) 11.23 (6.32) 12.76 (5.67)
    ES 1.13 0.47 1.31 0.42
    n 212 173 148 179
  SIDP-IV:
cluster AB
vs CNOS 
Baseline 16.52 (5.12) 14.95 (4.71) 16.22 (4.52) 15.62 (4.71)
  12 months 11.21 (5.84) 11.75 (5.34) 11.83 (6.44) 12.03 (5.84)
  ES 1.04 0.68 0.97 0.76
  n 141 244 89 238
  MTQ: total Baseline 14.87 (4.57) 16.35 (5.14) 14.80 (4.70) 16.70 (4.45)
    12 months 12.75 (5.34) 10.58 (5.40) 12.91 (5.56) 10.91 (6.42)
    ES 0.46 1.12 0.40 1.30
    n 198 182 158 169
GSI = Global Severity Index of the Brief Symptom Inventory, OQ-45 = Outcome questionnaire-45
SIPP = Severity Indices of Personality Pathology, DSQ: odf = Overall Defensive Functioning scale 
of the Defense Style Questionnaire, SIDP-IV: cluster AB vs CNOS = hierarchically clustered PD 
groups measured with the Structured Interview for DSM-IV Personality Disorders, MTQ = Motiva-
tion for Treatment Questionnaire
ES = effect size calculated as Cohen’s d
a  Effect of stabilzing and destabilzing psychotherapy presented for the two levels of patient’s 
psychological strenghts
b  The high versus low psychological strengths are operationalized with four different measures: 
SIPP, DSQ, SIDP-IV and MTQ, as presented in the second column.
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Corrected outcome
Table 5.3 shows the corrected effect sizes for patients with low versus high psy-
chological strengths, both in stabilizing and destabilizing psychotherapies, for 
each outcome variable and strength characteristic separately. Furthermore, the 
main effects of level of destabilization (low versus high), psychological strengths 
(low versus high), and the interaction effect between level of destabilization and 
psychological strengths on treatment outcome are shown.
Regarding the main effect of level of destabilization, destabilizing psycho-
therapies showed significantly more improvement on psychiatric symptoms than 
stabilizing treatments, for the strength variables: ‘severity of PD’ (SIDP-IV) and 
‘motivation for treatment’ (MTQ). Furthermore, destabilizing treatments were supe-
rior to stabilizing treatments in terms of their impact on relational functioning, only 
for the psychological strength ‘severity of PD’ (SIDP-IV). For social role functioning, 
we observe the superiority of destabilizing psychotherapies for the psychological 
strengths ‘defensive functioning’ (DSQ), ‘severity of PD’ (SIDP-IV) and motivation 
for treatment (MTQ).
Regarding the main effect of psychological strengths, patients high on psycho-
logical strengths show generally significantly better outcomes than patients low 
on psychological strength. This pattern is most obvious with respect to psychiatric 
symptoms and interpersonal relational outcome, and least obvious with respect to 
social role functioning.
Regarding the interaction effect between level of destabilization and psycho-
logical strengths, only one significant effect occurred. Patients low on adaptive 
personality functioning (SIPP) profit more from destabilizing than from stabilizing 
psychotherapy (which is the opposite towards our hypothesis), whereas patients 
high on adaptive personality functioning (SIPP) do equally well in both levels of 
destabilization (also not according to our hypothesis). This matching effect was 
observed for the improvement in terms of relational functioning, but not for the 
other outcome variables.
DiscUssion
In this study we investigated whether patients high on psychological strengths 
profit more from predominantly destabilizing treatments, whereas patients low 
on psychological strengths profit more from predominantly stabilizing treatments. 
This hypothesis is often stated in psychodynamic clinical literature (e.g. Gabbard 
(2005) and Winston, Rosenthal, & Pinsker (2004)) and used in clinical practice 
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when matching patients to psychotherapies (Van Manen, et al., 2012). However, 
in this large quasi experimental naturalistic study we cannot confirm this matching 
hypothesis. The findings do show main effects for the level of destabilization (i.e., 
high level of destabilization is associated with better outcomes) and psychological 
strengths (i.e., patients high on strengths have better outcomes than those low on 
strengths), but no interaction effects in line with the matching hypothesis. The only 
interaction effect that emerged, was opposite to our hypothesis.
Main findings
This study shows a positive impact of a high level of destabilization on treatment 
outcome, irrespective of psychological strengths and specific outcome variable. 
Furtheremore, to some extent this finding is in contrast with the prevailing view that 
too much pressure on vulnerable patients increases the risk of drop-out, difficulties 
to form a stable working alliance, and even psychotic decompensation (Horwitz, 
et al., 1996). Our finding suggests that even vulnerable patients profit from con-
frontative, expressive, and insight-oriented interventions. Moreover, we found a 
higher drop-out rate in the stabilizing therapy group. This finding is consistent with 
the dynamic systems theory perspective as described in the introduction (Hayes & 
Strauss, 1998; Thelen & Smith, 1994). We suspect that the majority of destabiliz-
ing treatments included in our sample, which were predominantly executed in an 
day-hospital or inpatient setting (86.6%), provide a highly structured and safe 
environment for patients to have corrective social-emotional experiences, to let 
go of their old dysfunctional patterns, and to experiment with and adopt new 
functional patterns. In other words, we suggest that these settings can provide the 
necessary positive holding environment patients need to work through the high 
anxiety levels that can occur in a insight-oriented treatment (Bateman & Fonagy, 
2001; Lorentzen & Hoglend, 2008).
Our finding that destabilizing psychotherapy has a more positive impact on 
treatment outcome then stabilizing psychotherapy contrasts with the results of the 
study of Piper et al. (Piper, Joyce, McCallum, & Azim, 1998; Piper, McCallum, 
Joyce, Azim, & Ogrodniczuk, 1999). They found in a randomised clinical trial, in 
an outpatient patient population with a majority suffering from PD, that interpretive 
psychotherapy provided the same effectiveness as the supportive psychotherapies. 
The diffences in outcome between our study and the study of Piper could be 
explained by the more intensive setting of the destabilzing treatments in our study. 
Our hypothesis is that PD patients can only profit fully from a high pressure, de-
stabilzing psychotherapy if the setting provides enough safety, that is for example 
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in a dayhospital or inpatient setting. In the study of Piper and colleagues the 
expressive therapy was (even as the supportive variant) in an outpatient setting.
Furthermore, this study revealed that patients high on psychological strengths, 
for instance, overall mature defensive functioning, benefit more from psycho-
therapy than patients low on psychological strengths, irrespective of the level of 
destabilization and specific outcome variable. This finding is in line with previous 
research indicating that healthier patients tend to do better in psychotherapy than 
more severely ill patients (Luborsky, et al., 1980). Possibly, healthier patients have 
psychological resources that enables them to profit from psychotherapy more 
than severely ill patients. Note that in our study ‘healthier’ does not mean ‘less 
psychiatric symptoms, and healthy interpersonal relations and social role’ as we 
entered these outcome measures at baseline in our multilevel model. The term 
healthier in this study is restricted to ‘psychological strengths’, e.g. motivation and 
overall defensive functioning.
The matching effect found in this study revealed that patients low on personal 
strengths profit more from a destabilizing treatment, and patients high on psycho-
logical strengths profit equally from destabilizing and stabilizing psychotherapies. 
This finding is opposite to our hypothesis. Perhaps a consistent reasoning accord-
ing to the dynamic systems theory can help us interpret this interaction effect: 
patients high on psychological strengths only require a limited adjustment within 
the same pattern or attractor state, whereas those low on psychological strengths 
require a major change including replacing dysfunctional patterns or attractor 
state by functional ones. Thus, destabilization is not necessary in those high on 
psychological strengths, while it is in their low-scoring counterparts.
Clinical and scientific implications
Our findings have two important clinical implications. First, our findings discour-
age clinical practice to routinely match patients low on psychological strengths to 
supportive or stabilizing variants of psychotherapy. Second, the overall positive 
effect of destabilizing psychotherapies in a PD population and the lack of evidence 
for a matching hypothesis strengthens the position of predominantly destabilizing 
psychotherapies or, at least, the application of expressive and confrontative tech-
niques within psychotherapeutic treatments. Destabilization seems to be beneficial 
for both the more vulnerable and the relatively healthier PD patient. However, 
our results do not preclude the possibility that destabilization can involve safety 
risks and thus iatrogenic effects for patients such as premature drop-out and dif-
ficulties in forming a stable working alliance. We would therefore recommend to 
apply destabilizing techniques in a well structured, safe, and holding therapeutic 
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environment. An approach to safety in psychotherapeutic environments is offered 
by Hutsebaut and colleagues, who distinguish between organizational, team and 
therapist adherence to a treatment model as necessary components of treatment 
integrity in the implementation of complex interventions for PD patients (Hutsebaut, 
Bales, Busschbach, & Verheul, 2012).
It is important to note that this study is the first study of treatment matching in 
PD, which is a highly complex domain of research. Replication of this study will 
help to build further on a clinically useful evidence base for practitioners, but 
only a replication of the results in this study in a randomized clinical trial will 
give enough evidence to implement the results in daily practice. Therefore RCTs 
are recommended. Furthermore, we would recommend future studies to elaborate 
on the potentially moderating role of the level of structure, safety and holding in 
the therapeutic environment, with a beneficial impact of destabilization in safe 
environments and a negative impact in unsafe environments.
Strengths and limitations
A clear strength of this study is its relatively high external validity. The study is 
conducted in clinical practice and not under stringent experimental conditions. 
Nevertheless, it should be recognized that all patients were referred and admitted 
to specialist psychotherapy. It can therefore not be precluded that our results are 
not applicable to PD patients who are not referred and admitted to specialist 
psychotherapy. A second strength is the large number of patients enabling the 
search for a matching effect. Despite these strengths the present findings have to 
be interpreted considering several limitations. First, although we controlled for 
pre-treatment differences or potential confounders using the propensity score, we 
cannot rule out that some potential confounders still influence the results (Bartak, 
et al., 2010). Furthermore we used an alternative propensity score enabling to 
find matching effects. For example we did not control for patient characteristics 
highly correlated with the concept of ‘psychological strengths’ in the propensity 
score. This concern is somewhat mitigated by the fact that reanalysing de data 
with or without several correlated strength characteristics in the propensity score 
did not alter the results. Furthermore, the main effect of destabilization and the 
lack of matching effects were observed with all variants of the propensity score. 
Further research is undertaken by our research group to investigate the use of the 
propensity score in subgroup analyses to optimize the power to find a matching 
effect, while simultaneously retaining control for confounding effects (Van Eeren, 
et al., 2011). A second limitation is that the treatments available in the destabiliz-
ing and stabilizing psychotherapies are a mixture of different settings, theoretical 
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orientations and durations (Table 1). One could argue that the effects we found 
can be attributed to the differences in for example the setting, not to the ‘level of 
(de)stabilization’ in the treatments. We considered however that the differences 
in duration and setting is inherent to the concept of ‘(de)stabilization of treat-
ment’. In other words: the setting and duration are not independent of the level of 
destabilization. Destabilizing treatments often use a ‘high pressure cooker model’ 
that yield good results in a relatively short time span. Stabilizing treatments use 
a more supportive and time-consuming trajectory. A third limitation concerns the 
operationalization and measurement of the concept ‘destabilization’. Although we 
have indications that the reliability of our operationalization is sufficient (correla-
tion among two ratings was r=.69), the validity of our operationalization might 
be improved. Further investigations could describe at a detailed level all possible 
stabilizing and destabilizing therapist interventions. Each treatment could then 
be scored on the most prominent interventions the therapist uses, for example by 
rating the videotaped sessions by multiple raters. A fourth limitation is that the 
operationalization of the psychological strength characteristics remains open for 
debate. We could not find one variable that captured the whole concept, and 
others have also outlined this definition problem (Bjorklund, 2000; Lake, 1985). 
In an attempt to overcome this problem, we decided to use four constructs likely 
to be highly associated to the ‘latent construct’ of psychological strengths. A fifth 
limitation is the presence of non-response in our data. This may cause a problem 
for internal validity if non-response is not at random, but related to systematic bias 
in effect estimation. However, this bias seems unlikely because responders and 
non-responders did not differ in psychiatric symptoms at baseline, and therefore 
it seems that they do not represent two structurally different groups of patients 
(Bartak, et al., 2010).
conclUsion
In conclusion our findings do not encourage clinical practice to routinely match 
patients low on psychological strengths to supportive or stabilizing variants of psy-
chotherapy, and may encourage to routinely consider predominantly destabilizing 
psychotherapies as an interesting treatment option in these patients. These findings 
are in favor of the position of destabilizing psychotherapies in the treatment of PD 
patients.
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DiscUssion
This thesis aims to contribute to evidence-based treatment selection for patients 
with PD. The findings presented suggest that treatment selection is a complex 
task due to the different manifestations of PD and the wide variety of effective 
psychotherapeutic treatments in terms of setting, duration, intensity and theoretical 
orientations. Treatment selection appears a largely implicit and poorly understood 
process, which at least in part explains why there are no evidence based guide-
lines available yet. It is reasonable to assume that clinicians can profit from more 
understanding of the treatment selection process and of concrete guidelines. It 
has been hypothesized that a good fit between patient and treatment will make 
treatment more effective. In that respect it would be helpful if one could formu-
late ‘matching relation(s)’ between patient characteristic (such as diagnosis and 
sociodemographics) and specific treatment characteristic (such as setting, dura-
tion, intensity). This thesis aims at finding such matching relation(s) with the use 
of the ‘evidence-based medicine model’ (Sackett, Rosenberg, Gray, Haynes, & 
Richardson, 1996). This model integrates a) clinical knowledge, b) routine clinical 
practice, and c) empirical evidence. As a result the research questions were as 
follows:
A. Clinical knowledge
 1.  What patient characteristics are considered relevant to treatment selection 
for patients with PD?
 2.  What matching hypotheses underlie or implicitly underlie clinical practice 
of treatment selection for patients with PD?
B. Routine clinical practice
 3.  What is the relationship between characteristics of patients with PD and 
treatment allocation in routine clinical practice?
C. Empirical evidence
 4.  Do patients with high psychological strength profit more from predomi-
nantly destabilizing treatments; and do patients with low psychological 
strength profit more from predominantly stabilizing treatments?
answers to the research qUestions
1) What patient characteristics are considered relevant to treatment selection for 
patients with PD?
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To answer this question the concept mapping method was used: a formalized 
conceptualization procedure which explicates implicit knowledge such as treat-
ment selection. Based on both a literature search and the expert opinions of 29 
Dutch clinicians in PD a concept map was constructed that revealed eight relevant 
patient characteristics: 1) severity of symptoms; 2) severity of personality pathol-
ogy; 3) ego-adaptive capacities; 4) motivation and working alliance; 5) social 
context; 6) social demographic characteristics; 7) trauma and treatment history; 
and 8) medical condition. These eight clusters could be ordered along two bipolar 
axes, running from ‘internal- to external characteristics’ and from ‘vulnerability- to 
strength concepts’.
2) What matching hypotheses underlie or implicitly underlie clinical practice of 
treatment selection for patients with PD?
Twenty-seven Dutch clinical experts in PD were interviewed to investigate the rel-
evance of 48 possible matching hypotheses. These consisted of a preset of patient 
characteristics on the one hand, and setting, duration, intensity and theoretical 
orientation of a psychotherapeutic treatment on the other hand. None of the pre-
selected patient characteristics was deemed relevant for setting. Personal strength 
characteristics and indicators of severity of pathology were thought relevant for 
duration and intensity. Lastly, the experts would select the theoretical orientation 
on the basis of personal strength variables.
3) What is the relationship between characteristics of patients with PD and treat-
ment allocation in routine clinical practice?
In a large multicenter study (the SCEPTRE study), the routine clinical practice of 
treatment selection was investigated. All patients (N = 923) enrolled in the study 
received the routine intake procedure. The resulting treatment allocation was 
related to characteristics measured before the intake procedure. Treatment alloca-
tion was defined in terms of setting (outpatient, day hospital and inpatient) and 
duration (long, short). The most prominent predictors for setting were: symptom 
distress, cluster C personality pathology, level of identity integration, treatment 
history, motivation and parental responsibility. The most prominent predictor 
for duration was age. It was concluded that treatment selection is a multifactor 
decision process, and that in addition to pathology and motivational descriptors, 
sociodemographics and treatment history are related to allocation.
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4) Do patients with high psychological strength profit more from predominantly 
destabilizing treatments; and do patients with low psychological strength profit 
more from predominantly stabilizing treatments?
The consulted experts hypothesized that the match between personal strengths 
and the level of destabilization of the treatment is one of the key principles that 
determine treatment selection. This hypothesis was based on the data of clini-
cal practice. More specifically, this hypothesis formulates that patients with high 
psychological strength profit more form a destabilizing treatment and patients with 
low personal strength profit more from a stabilizing treatment. This hypothesis was 
tested in the data set of the quasi-experimental SCEPTRE study, using data of 735 
PD patients who received treatment in 6 psychotherapy centers in the Netherlands. 
The data was analyzed using multilevel modeling to estimate outcome at 12 
months after baseline. The propensity score method was employed to control for 
initial baseline differences in the quasi experimental dataset. The findings showed 
that destabilizing psychotherapies have better outcomes than stabilizing psycho-
therapies. Furthermore, patients with high psychological strengths showed more 
improvement than patients with low psychological strengths. The hypothesized 
matching relation could not be confirmed however. What is more, one of the 12 
tested matches was positive in the opposite direction as hypothesized. This means 
that all patients, irrespective of their personal strength, benefit from destabilizing 
therapies.
Practical imPlications for roUtine clinical care
1. Even patients with little psychological strengths can profit from destabilizing 
treatments.
Chapter 5 shows that a high level of destabilization has a positive impact on 
treatment outcome – irrespective of level of psychological strengths and of specific 
outcome variables. This finding suggests that even vulnerable patients profit as 
much as their healthier counterparts from confrontative, expressive, and insight-
oriented interventions. This notion may be new to professionals who believe that 
patients with low personal strengths should receive supportive, stabilizing, low 
impact treatment. An often heard argument in this respect is that patients with 
low personal strengths would be harmed by high pressure treatment. It could 
mean a demanding, depriving and anxiety arousing experience for the patient, 
due for example to the pressure to talk, the absence of gratification and praise, 
and the interpretation of transference. One could argue that patients with low 
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personal strength cannot cope with these higher arousal levels and as a result 
develop more psychiatric symptoms, such as psychotic decompensation, induced 
depressions, suicidal acts, or reduced therapy compliance. However, high pres-
sure treatment does not necessarily endanger patients’ safety and wellbeing. It will 
be adapted to the level of arousal that the patient can cope with, and will have 
a clear focus of treatment, provide guidance about what to do when a patient is 
in crisis, ensure continuity of staff members, and integrate treatment in the social 
network (Hutsebaut, Bales, Busschbach, & Verheul, 2012). Given such safeguards 
and structure, the results of this thesis show that even patients with a low level of 
personal strengths can profit from destabilizing treatments.
2. The allocation process should focus on, but not restrict to, treatment history, 
motivation and the social context when planning treatment of the patient.
Treatment selection in PD is a multifactor process. As described in chapters 2 and 
4, internal patient factors (like reflective capacity, identity integration, capacity 
to relate) as well as external factors (like systemic problems, outstanding debts, 
cultural background, having children, having a job) are important when selecting 
treatment. Looking across the different studies in this thesis, some patient charac-
teristics stand out.
i. First, treatment history: patients for whom low doses of psychotherapy were not 
successful need to step up to a therapy with a higher dosage, which means a 
more intensive setting, e.g. day hospital or inpatient setting, more sessions in a 
week, or involving family in therapy. This allocation rule is also referred to as 
the ‘stepped care principle’ (Davison, 2000).
ii. Second, more motivated patients are eligible for a higher dosage of treatment. 
According to the expert clinicians, motivation can work as a positive moderator 
in the psychotherapy process, and consequently enhance the treatment effect.
iii. The third patient characteristic is the social context. Being a parent is especially 
a factor that limits the treatment options, e.g. long term inpatient psychotherapy. 
Other decisive social variables include: wish to continue study, considerable 
outstanding debts, and severe systemic problems.
One caveat should be mentioned however; these allocation rules have not been 
tested on their effectiveness. Nevertheless, as they were found in multiple studies 
in which clinical experts express best clinical practice, in terms of evidence based 
medicine they can therefore be considered as ‘best practices’.
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limitations
Several limitations of the research presented in this thesis have been addressed 
in the discussion paragraphs of the different chapters. Below some limitations are 
discussed which have not yet be dealt with or are important generic limitations 
which apply to most chapters.
First; despite careful considerations, extensive consultations with expert clini-
cians, and searching for relevant literature, the selection and definition of the 
patient characteristics was limited, often due to practical reasons (e.g. no valid 
questionnaire was available for a specific variable) or because clinicians had 
difficultly describing the clinical features of their patients, like personal strength. A 
similar limitation applies to the operationalization of ‘treatment’ in terms of setting, 
duration, and level of destabilization. Moreover, in the different settings there was 
a mixture of different treatment orientations. Furthermore, it was often necessary to 
dichotomize the patient and treatment characteristics, which reduced the sensitiv-
ity of the analysis. Despite these limitations, the conclusions still hold. For instance, 
‘personal strength’ was operationalized in four different ways. Moreover, we used 
a large data set to assure enough power to detect statistically significant relations.
Second, several possible determinants for treatment allocation were not 
included, such as: clinician preferences or theoretical orientation (Witteman & 
Koele, 1999), patient-therapist relationship factors (Norcross, 2002) and local 
availability of treatment facilities (Chiesa, Bateman, Wilberg, & Friis, 2002; Is-
sakidis & Andrews, 2003; Van Audenhove & Vertommen, 2000).
Third, in the Netherlands a wide variety of modalities of specialist psycho-
therapy for PD is available. The data used in this thesis may therefore not be 
representative for all Dutch centers that treat PD. It can be stated with certainty, 
however, that the data is not representative in an international perspective, as 
inpatient psychotherapy for PD patients is hardly offered outside the Netherlands. 
Furthermore, it cannot be excluded that the patient population has changed since 
the start of the SCEPTRE study. For instance, De Viersprong institution currently 
employs a policy to admit patients with more intensive symptoms.
Fourth, the complex higher order interactions between multiple patient char-
acteristics and treatments were not considered. For example, in reality patient 
characteristics might interact so that the impact of a characteristic is contingent 
on different levels of another variable. Research in this thesis was limited to single 
factor matching associations.
Fifth, confounding of treatment integrity (organizational factors, therapist 
adherence, clear focus of treatment etc.) and level of destabilization cannot be 
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excluded. A therapy with a high level of destabilization requires a consistent and 
safe environment with, for example, a clear focus in treatment, a safety plan, and 
staff adhering to the treatment manual. The beneficial effect of level of destabiliza-
tion could therefore also be attributed to sufficient treatment integrity.
sUggestions for fUrther research
The findings of this thesis are based on a naturalistic study design. Given that 
a randomized design provides a higher level of evidence, a next step should 
be to test these findings in a randomized controlled trial in which patients are 
randomly admitted to stabilizing and destabilizing therapies. The challenge will 
be to protocolize these therapies and to operationalize personal strength.
The factors underlying the success of destabilizing therapies could be a next 
field of exploration: is it the destabilization itself that leads to success, or is it a 
highly structured en integer clinical environment that pushes the effects?
If personal strength is (still) seen as a relevant clinical variable, if would be 
helpful if consensus could be reached on how to operationalize it.
conclUsions
Clinicians use many different matching relations when allocating patients with PD 
to treatment, but the consensus on the matching relations is limited to: 1) social con-
text, especially parental responsibility; 2) motivation; 3) treatment history, which 
results in application of the stepped care principle; and 4) matching between 
personal strength and the level of stabilization or destabilization in treatment. 
In this thesis this matching relation is tested in a large clinical population, but 
we were unable to confirm its effectiveness: destabilizing treatments gave better 
results regardless of the patient’s personal strengths. This implies that clinicians 
should hold modest expectations for their allocation practices, while at the other 
hand one could be optimistic about destabilizing treatments.
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summary
sUmmary
This thesis deals with the topic of treatment selection of psychotherapy for patients 
with personality disorder (PD).
In chapter 1 is the need for such research explained. Patients with PD have 
impaired well-being and they have problems in multiple areas such as partner 
relations, work and friendships. Consensus has grown that psychotherapy is the 
treatment of choice for these patients. Psychotherapies for PD vary in setting (e.g. 
outpatient versus inpatient), duration (e.g. short-term versus long-term), format (e.g. 
individual versus group), and theoretical background (e.g. cognitive behavioural 
versus psychodynamic). This variety raises the question of treatment selection: 
which setting, duration, format or theoretical background should be selected for a 
specific patient with PD. However, as yet, this question has not been investigated 
empirically. This thesis contributes to evidence-based treatment selection for patients 
with PD. The primary aim was to investigate expert clinical knowledge, routine 
clinical practice, and matching hypotheses of treatment selection for patients with 
PD. The secondary aim was to thereby contribute to evidence-based treatment 
selection in clinical practice. In this context, following research questions were 
addressed:
1. What patient characteristics are considered relevant to treatment selection for 
patients with PD?
2. What matching hypotheses underlie or implicitly underlie clinical practice of 
treatment selection for patients with PD?
3. What is the relationship between characteristics of patients with PD and treat-
ment allocation in routine clinical practice?
4. Do patients with high psychological strength profit more from predominantly 
destabilizing treatments; and do patients with low psychological strength profit 
more from predominantly stabilizing treatments?
In chapter 2 the concept map method is described, which serves to summarize 
and describe patient characteristics pertinent to treatment selection in PD patients. 
Patient characteristics were derived from the research literature and a survey 
among Dutch expert clinicians. Concept mapping is a formalized conceptualiza-
tion procedure that describes the underlying cognitive structures people use in 
complex tasks, such as treatment allocation. Based on expert opinions of 29 Dutch 
clinicians, a concept map was generated that yielded eight domains of patient 
characteristics, i.e. Severity of symptoms, Severity of personality pathology, Ego-
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adaptive capacities, Motivation and working alliance, Social context, Social de-
mographic characteristics, Trauma, and Treatment history and medical condition. 
These domains can be ordered along two bipolar axes, running from internal to 
external concepts and from vulnerability to strength concepts, respectively. Our 
findings may serve as input for the delineation of algorithms for patient-treatment 
matching research in PD.
Chapter 3 reports how intake clinicians use information about patient character-
istics to select psychotherapeutic treatment for PD patients. A structured interview 
with a forced-choice format was administered to 27 experienced intake clinicians 
working in five specialist mental health care institutions in the Netherlands. Sub-
stantial consensus was evident, in that none of the presented patient characteristics 
was deemed relevant for the selection of the suitable treatment setting. These intake 
clinicians select duration and intensity of treatment on the basis of severity of the 
PD or personal strength variables. The theoretical orientation is selected on the 
guidance of the patient’s personal strength variables.
Chapter 4 reports on the relationship between patient characteristics and treat-
ment allocation in a large multi-center study in PD patients. Personality pathology, 
symptom distress, treatment history, motivational factors, and sociodemographics 
were measured at intake in 923 patients, who subsequently were enrolled in short-
term or long-term outpatient, day hospital, or inpatient psychotherapy. Predictors 
of allocation decisions were examined with logistic regression analyses. The 
relationship between patient characteristics and treatment setting was moderate 
(R2 = 0.36), and the relationship between patient characteristics and treatment 
duration was weak (R2 = 0.18). The most relevant predictors for setting were: 
symptom distress, cluster C personality pathology, level of identity integration, 
treatment history, motivation, and parental responsibility. The most relevant predic-
tor for duration was age. We conclude from this study that apart from pathology 
and motivation factors, sociodemographics and treatment history are related to 
treatment allocation in clinical practice.
In chapter 5 the matching hypothesis is tested that patients high on psychological 
strengths profit more from destabilizing psychotherapy, whereas patients low on 
strengths profit more from stabilizing psychotherapy. The data of the SCEPTRE study 
was used. SCEPTRE is a quasi-experimental study conducted between 2003 and 
2008 in 735 patients with personality disorders from 6 psychotherapy centers in 
the Netherlands. To test the matching hypothesis patients were assigned to differ-
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ent levels of stabilizing and destabilizing psychotherapies. Levels of psychological 
strengths were measured. A multilevel model was used to estimate outcome at 
12 months after baseline. The propensity score controlled for initial differences 
at baseline. The findings show that destabilizing psychotherapies have slightly 
better outcomes than stabilizing psychotherapies. Patients with high psychological 
strengths improve slightly more than do patients with low psychological strengths. 
The observed interaction effect contradicted our hypothesis. The results imply that 
destabilizing psychotherapies can be considered as first treatment option irrespec-
tive of a patient’s level of psychological strength.
In chapter 6 the answers to the research questions stated in the introductory 
chapter of this thesis are presented. The practical implication is that a high level 
of destabilization has a positive impact on treatment outcome irrespective of psy-
chological strengths and specific outcome variables. This finding suggests that 
vulnerable patients as much as their healthier counterparts profit from confronta-
tive, expressive, and insight oriented interventions. It is recommended that high 
pressure treatments should take place in a safe environment providing a clear 
focus of treatment, clarity about what to do when a patient is in crisis, continuity of 
staff members, and integration of treatment in the social network. Another relevant 
finding is that three patient characteristics are consistently related to treatment 
selection: 1) stepped-care: treatment history: patients for whom low doses of psy-
chotherapy were not successful need to step up to a therapy with a higher dosage, 
which means a more intensive setting, e.g. day hospital or inpatient setting, more 
sessions in a week, or involving family in therapy; 2) motivation: more motivated 
patients are eligible for a higher dosage of treatment. Motivation can work as a 
positive moderator in the psychotherapy process, thus enhancing the treatment 
effect; 3) social context, especially parental responsibility is a factor that limits the 
possibility for e.g. long term inpatient psychotherapy. In this chapter the limitations 
of the research are discussed. Noteworthy in this respect are: 1) the limited selec-
tion and operationalization of the patient characteristics and the limited opera-
tionalization of treatment in terms of setting, duration, and level of destabilization, 
combined with the need to dichotomize these characteristics, which reduces the 
validity of the results; 2) the low generalizability of the findings to all types of PD 
and all treatments as well as to countries other than the Netherlands.
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neDerlanDse samenvatting
Het onderwerp van dit proefschrift is indicatiestelling bij persoonlijkheidsstoornis-
sen (PS).
In hoofdstuk 1 wordt uitgelegd waarom onderzoek naar indicatiestelling bij 
persoonlijkheidsstoornissen nodig is. Patiënten met PS worden geassocieerd 
met een lager welzijn en meerdere problemen op het gebied van bijvoorbeeld 
relaties, vriendschap en werk. Psychotherapie wordt beschouwd als eerste keus 
behandelmethode bij patiënten met PS. Psychotherapie is er in veel verschillende 
vormen zoals de settting (ambulant versus opname), duur (langer durende therapie, 
versus korte therapie), format (individueel versus groepstherapie) en theoretische 
achtergrond (psychodynamisch, cognitief gedragstherapeutisch). Deze verschil-
lende mogelijkheden roepen de klassieke vraag op naar indicatiestelling: “Welke 
setting, duur, format en theoretisch kader moet worden geïndiceerd voor deze 
specifieke PS patiënt?”. Naar indicatiestelling bij PS is nog geen empirisch onder-
zoek gedaan. Door deze vraagstelling in dit proefschrift te onderzoeken, wordt 
een bijdrage geleverd aan de evidence based indicatiestelling bij mensen met PS. 
Het doel van het onderzoek was om klinische kennis van experts en gegevens uit 
de dagelijkse praktijk te operationaliseren, en hieruit indicatieregels (matching 
hypotheses) voor mensen met PS op te stellen en deze empirisch te toetsen. De 
volgende onderzoeksvragen worden in dit proefschrift besproken:
1. Welke patiëntkenmerken worden door experts van belang geacht voor indica-
tiestelling bij patiënten met PS?
2. Welke indicatiestellingregels (matching hypotheses) kunnen worden opgesteld 
aan de hand van ervaringskennis?
3. Wat is de relatie tussen kenmerken van patiënten met PS en de geïndiceerde 
behandeling in de dagelijkse praktijk?
4. Profiteren patiënten die hoog scoren op psychologische capaciteiten meer van 
voornamelijk destabiliserende behandelingen en profiteren patiënten die laag 
scoren op psychologische capaciteiten meer van stabiliserende behandelin-
gen?
In hoofdstuk 2 wordt de ‘concept map methode’ beschreven; deze methode ana-
lyseert en beschrijft de onderliggende factoren die van belang zijn voor indicatie-
stelling bij PS patiënten. Patiëntkenmerken werden vastgesteld met behulp van een 
literatuuronderzoek en een vragenlijst onder ervaren Nederlandse behandelaren. 
Op basis van de input van de 29 clinici, werd een concept map geconstrueerd 
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die bestaat uit acht domeinen van patiëntkenmerken. Deze kenmerken zijn: ernst 
van de psychiatrische symptomatologie, ernst van de persoonlijkheidspathologie, 
ego-adaptieve vermogens, motivatie en vermogen tot het aangaan van een 
werkrelatie, sociale context, socio-demografische variabelen, traumatisering en 
behandelgeschiedenis en somatiek. De acht domeinen kunnen geplaatst worden 
in een tweedimensionaal vlak met twee assen: één as loopt van interne naar 
externe factoren en de andere as die loopt van psychologische kwetsbaarheid 
naar psychologische kracht of stevigheid. De bevindingen kunnen dienen als 
eerste aanzet voor indicatiestellingsonderzoek, zoals matchingsonderzoek bij PS.
Hoofdstuk 3 beschrijft hoe intakers patiëntkenmerken gebruiken in de intake om 
een psychotherapeutische behandeling voor PS patiënten te selecteren. Er zijn 27 
ervaren intakers uit vijf verschillende instellingen in Nederland geïnterviewd met 
behulp van een gestructureerd interview met multiple choice vragen. Er bestond 
onder de intakers een aanzienlijke mate van overeenstemming over het gebrek 
aan relevantie van de gepresenteerde patiëntkenmerken voor de selectie van een 
specifieke setting (ambulant, dagklinisch, klinisch). Intakers gebruiken de ernst 
van de PS en de mate van psychologische capaciteiten wanneer ze de duur en 
de intensiteit van de behandelingen selecteren. Het theoretische kader van de 
behandeling wordt volgens de geïnterviewde intakers gekozen aan de hand van 
de psychologische capaciteiten van een patiënt.
Hoofdstuk 4 beschrijft het verband tussen patiëntkenmerken van PS en de uit-
eindelijk ontvangen behandeling in de grote multicenter SCEPTRE studie. In deze 
quasi-experimentele studie werden 923 PS patiënten na de intake toegewezen aan 
verschillende, langer en korter durende behandelingen met verschillende settin-
gen: ambulant, dagklinisch of klinisch. Persoonlijkheidspathologie, psychiatrische 
symptomen, behandelgeschiedenis, motivatie en sociodemografische gegevens 
werden gemeten aan de start van de intake. Predictoren voor het uiteindelijke be-
handeladvies (in termen van setting en duur) werden vastgesteld met behulp van 
logistische regressie. Het verband tussen de patiëntkenmerken en de setting van 
de behandeling was matig (R2 = 0.36), het verband tussen de patiëntkenmerken 
en de duur van de behandeling was zwak (R2 = 0.18). De significante predicto-
ren voor setting waren: lijdensdruk, Cluster C PS, mate van identiteitsintegratie, 
behandelgeschiedenis, motivatie en ouderschap. De significante predictor voor 
duur was leeftijd. Uit deze studie concluderen we dat naast de meer algemeen 
aanvaarde factoren zoals pathologie en motivatie, sociodemografische gegevens 
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en behandelgeschiedenis belangrijk zijn voor indicatiestelling in de dagelijkse 
praktijk.
In Hoofdstuk 5 wordt de ‘matching hypothese’ getoetst welke beschrijft dat 
patiënten die hoog scoren op psychologische capaciteiten meer profiteren van 
destabiliserende psychotherapie en patiënten die laag scoren op psychologische 
capaciteiten meer profiteren van stabiliserende psychotherapie. Om deze hypo-
these te toetsen werden data van de eerder genoemde SCEPTRE studie gebruikt. 
In dit onderzoek werden 735 patiënten met een persoonlijkheidsstoornis vanuit 
6 psychotherapeutische instellingen in Nederland gevolgd. Patiënten werden 
geïndiceerd naar verschillende niveaus van stabiliserende en destabiliserende 
psychotherapieën. Het niveau van psychologische capaciteiten werd gemeten 
met vragenlijsten. Met behulp van een multilevel model werd de uitkomst van 
de behandeling op 12 maanden na de baseline meting geschat. De propensity 
score werd gebruikt om te controleren voor initiële verschillen tussen patiënten 
op baseline. De resultaten laten zien dat destabiliserende therapieën iets betere 
uitkomsten hebben dan stabiliserende psychotherapieën. Verder profiteren pati-
enten die hoger scoren op psychologische capaciteiten meer dan patiënten die 
lager scoren op psychologische capaciteiten. De matching hypothese kon niet 
worden bevestigd, we vonden juist één tegenovergesteld effect. De implicatie van 
deze studie is dat destabiliserende behandelingen overwogen kan worden als 
eerste keus behandeling ongeacht de mate van psychologische capaciteiten van 
de patiënten.
In hoofdstuk 6 worden de antwoorden op de onderzoeksvragen uit de intro-
ductie beantwoord. De belangrijkste bevinding van dit proefschrift is dat een 
hoge mate van destabilisering een positief effect heeft op de behandeluitkomst, 
onafhankelijk van psychologische capaciteiten van de patiënt en onafhankelijk 
van de gebruikte uitkomstmaat. Dit impliceert dat als kwetsbare beschouwde pati-
enten net zoveel profiteren van confronterende, interpreterende behandelingen als 
patiënten met meer psychologische capaciteiten. Destabiliserende behandelingen 
moeten plaatsvinden in een consistente, coherente en continue omgeving wat 
bijvoorbeeld tot uiting komt in een duidelijk behandelbeleid bij crisis, continuïteit 
van therapeuten en een integratie van de behandeling in de sociale omgeving van 
patiënten. Verder blijkt uit huidig onderzoek dat drie factoren relevant zijn voor 
de indicatiestelling: 1) het ‘stepped-care’ principe: patiënten die onvoldoende 
hebben geprofiteerd van een lage dosis van psychotherapie ‘step up’ naar een 
hogere dosis van psychotherapie, bv dagklinische behandeling in plaats van 
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ambulant, of meer sessies per week, 2) motivatie: meer gemotiveerde patiënten 
komen in aanmerking voor intensievere behandelingen, aangezien motivatie 
kan functioneren als een positieve moderator in het behandelproces, 3) sociale 
context, met name verantwoordelijkheid dragen voor kinderen, is een factor die 
in grote mate de behandelmogelijkheden kan belemmeren, bijvoorbeeld bij 
langdurige klinische opname. In dit hoofdstuk worden ook de beperkingen van 
de onderzoeken uit huidig proefschrift beschreven. De belangrijkste zijn: 1) de 
selectie en operationalisatie van de patiëntkenmerken en operationalisatie van 
behandeling in termen van setting, duur en mate van destabilisatie, naast het 
dichotomiseren van zowel de patiënt- als de behandelingsvariabelen beperken de 
validiteit van de resultaten, 2) de lage generaliseerbaarheid van de bevindingen 
naar alle verschillende typen PS en naar anderen landen dan Nederland.
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